10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________________

FORM 10-Q

_________________________

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended September 30, 2013

OR

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from________ to________ .

Commission File Number: 1-644

COLGATE-PALMOLIVE COMPANY

(Exact name of registrant as specified in its charter)

DELAWARE	13-1815595
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

300 Park Avenue, New York, New York	10022
(Address of principal executive offices)	(Zip Code)

(212) 310-2000

(Registrant’s telephone number, including area code)

NO CHANGES

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x  No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One):

Large accelerated filer x	Accelerated filer ¨
Non-accelerated filer ¨	Smaller reporting company ¨

(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class	Shares Outstanding	Date
Common stock, $1.00 par value	925,208,785	September 30, 2013

PART I.FINANCIAL INFORMATION

COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Dollars in Millions Except Per Share Amounts)

(Unaudited)

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2013		2012		2013			2012
Net sales	$	4,398	$	4,332	$	13,059		$	12,799
Cost of sales	1,813		1,803		5,425			5,372
Gross profit	2,585		2,529		7,634			7,427
Selling, general and administrative expenses	1,549		1,501		4,611			4,443
Other (income) expense, net	20		1		359			37
Operating profit	1,016		1,027		2,664			2,947
Interest (income) expense, net	—		4		(8		)	20
Income before income taxes	1,016		1,023		2,672			2,927
Provision for income taxes	317		326		863			932
Net income including noncontrolling interests	699		697		1,809			1,995
Less: Net income attributable to noncontrolling interests	43		43		132			121
Net income attributable to Colgate-Palmolive Company	$	656	$	654	$	1,677		$	1,874
Earnings per common share, basic	$	0.71	$	0.69	$	1.80		$	1.96
Earnings per common share, diluted	$	0.70	$	0.68	$	1.78		$	1.95
Dividends declared per common share	$	0.34	$	0.31	$	1.33		$	0.91

See Notes to Condensed Consolidated Financial Statements.

2

COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Dollars in Millions)

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2013			2012			2013			2012
Net income including noncontrolling interests	$	699		$	697		$	1,809		$	1,995
Other comprehensive income, net of tax
Cumulative translation adjustments	90			89			(165		)	(23		)
Retirement Plan and other retiree benefit adjustments	18			25			56			35
Gains (losses) on available-for-sale securities	3			(5		)	7			9
Unrealized gains (losses) on cash flow hedges	(5		)	(2		)	—			3
Total Other comprehensive (loss) income, net of tax	106			107			(102		)	24
Total Comprehensive income including noncontrolling interests	805			804			1,707			2,019
Less: Net income attributable to noncontrolling interests	43			43			132			121
Less: Cumulative translation adjustments attributable to noncontrolling interests	(3		)	8			(7		)	4
Total Comprehensive income attributable to noncontrolling interests	40			51			125			125
Total Comprehensive income attributable to Colgate-Palmolive Company	$	765		$	753		$	1,582		$	1,894

See Notes to Condensed Consolidated Financial Statements.

3

COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in Millions)

(Unaudited)

	September 30, 2013			December 31, 2012
Assets
Current Assets
Cash and cash equivalents	$	721		$	884
Receivables (net of allowances of $65 and $61, respectively)	1,737			1,668
Inventories	1,441			1,365
Other current assets	701			639
Total current assets	4,600			4,556
Property, plant and equipment:
Cost	8,051			7,821
Less: Accumulated depreciation	(4,193		)	(3,979		)
	3,858			3,842
Goodwill, net	2,471			2,500
Other intangible assets, net	1,487			1,499
Deferred income taxes	91			92
Other assets	932			905
Total assets	$	13,439		$	13,394
Liabilities and Shareholders’ Equity
Current Liabilities
Notes and loans payable	$	19		$	54
Current portion of long-term debt	588			250
Accounts payable	1,234			1,290
Accrued income taxes	283			254
Other accruals	2,367			1,888
Total current liabilities	4,491			3,736
Long-term debt	4,677			4,926
Deferred income taxes	312			293
Other liabilities	1,952			2,049
Shareholders’ Equity
Common stock	1,466			1,466
Additional paid-in capital	912			818
Retained earnings	17,393			16,953
Accumulated other comprehensive income (loss)	(2,716		)	(2,621		)
Unearned compensation	(35		)	(41		)
Treasury stock, at cost	(15,236		)	(14,386		)
Total Colgate-Palmolive Company shareholders’ equity	1,784			2,189
Noncontrolling interests	223			201
Total shareholders’ equity	2,007			2,390
Total liabilities and shareholders’ equity	$	13,439		$	13,394

See Notes to Condensed Consolidated Financial Statements.

4

COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in Millions)

(Unaudited)

	Nine Months Ended
	September 30,
	2013			2012
Operating Activities
Net income including noncontrolling interests	$	1,809		$	1,995
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	329			317
Restructuring and termination benefits, net of cash	82			(35		)
Voluntary benefit plan contributions	(101		)	(101		)
Stock-based compensation expense	105			98
Venezuela devaluation charge	172			—
Deferred income taxes	35			71
Cash effects of changes in:
Receivables	(137		)	(166		)
Inventories	(107		)	(48		)
Accounts payable and other accruals	121			(27		)
Other non-current assets and liabilities	57			29
Net cash provided by operations	2,365			2,133
Investing Activities
Capital expenditures	(419		)	(317		)
Sale of property and non-core product lines	—			38
Purchases of marketable securities and investments	(408		)	(501		)
Proceeds from sale of marketable securities and investments	195			120
Payment for acquisitions, net of cash acquired	—			(29		)
Other	4			65
Net cash used in investing activities	(628		)	(624		)
Financing Activities
Principal payments on debt	(5,504		)	(3,684		)
Proceeds from issuance of debt	5,563			4,131
Dividends paid	(1,030		)	(951		)
Purchases of treasury shares	(1,115		)	(1,344		)
Proceeds from exercise of stock options and excess tax benefits	276			390
Net cash used in financing activities	(1,810		)	(1,458		)
Effect of exchange rate changes on Cash and cash equivalents	(90		)	(20		)
Net increase (decrease) in Cash and cash equivalents	(163		)	31
Cash and cash equivalents at beginning of the period	884			878
Cash and cash equivalents at end of the period	$	721		$	909
Supplemental Cash Flow Information
Income taxes paid	$	781		$	949

See Notes to Condensed Consolidated Financial Statements.

5

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

1. Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

For a complete set of financial statement notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2012, filed with the Securities and Exchange Commission.

2. Use of Estimates

Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

3. Recent Accounting Pronouncements

In July 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-10 “Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes”. ASU No. 2013-10 permits the Fed Funds Effective Swap Rate to be used as a benchmark interest rate for hedge accounting purposes and eliminates the restriction on using different benchmark interest rates for similar hedges. The new guidance is effective immediately and can be applied prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. This new guidance is not expected to have a material impact on the Company’s financial position or results of operations.

In July 2013, the FASB issued ASU No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”. ASU No. 2013-11 requires an entity to net its liability for unrecognized tax benefits against the deferred tax assets for all same jurisdiction net operating losses or similar tax loss carryforwards, or tax credit carryforwards. A gross presentation will be required only if such carryforwards are not available as of reporting date to settle any additional income taxes resulting from disallowance of the uncertain tax position or the entity does not intend to use these carryforwards for this purpose. The new guidance is effective on a prospective basis for fiscal years beginning after December 15, 2013 and interim periods within those years. This new guidance is not expected to have a material impact on the Company’s financial position or results of operations.

4. Acquisitions and Divestitures

Sale of Land in Mexico

On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The Company is re-investing these payments to relocate its soap production to a new state-of-the-art facility to be constructed at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. As a result, the Company expects to make capital improvements and incur costs to exit the site through 2014. These exit costs will primarily be related to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. During the three months endedSeptember 30, 2013 and 2012, the Company incurred $3 and $7 of pretax costs ($2 and $5 of aftertax costs), respectively, related to the sale. During the nine months endedSeptember 30, 2013 and 2012, the Company incurred $14 and $20 of pretax costs ($9 and $15 of aftertax costs), respectively, related to the sale.

6

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

5. Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program (the 2012 Restructuring Program) for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

Implementation of the 2012 Restructuring Program is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax), which are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (15%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (15%). Due to the acceleration of the implementation of certain program initiatives, the anticipated pretax charges for 2013 increased to approximately $365 to $390 ($290 to $305 aftertax) from approximately $260 to $310 ($185 to $220 aftertax) with no change to the amount of expected total program charges. Over the course of the 2012 Restructuring Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis.

For the three and nine months ended September 30, 2013, restructuring and implementation-related charges are reflected in the income statement as follows:

	Three Months Ended		Nine Months Ended
	September 30, 2013		September 30, 2013
Cost of sales	$	8	$	26
Selling, general and administrative expenses	9		31
Other (income) expense, net	13		141
Total 2012 Restructuring Program charges, pretax	$	30	$	198
Total 2012 Restructuring Program charges, aftertax	$	22	$	153

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges for the 2012 Restructuring Program for the three months endedSeptember 30, 2013 relate to initiatives undertaken in North America (13%), Europe/South Pacific (22%), Latin America (6%), Hill’s Pet Nutrition (29%) and Corporate (30%). Total charges for the 2012 Restructuring Program for the nine months endedSeptember 30, 2013 relate to initiatives undertaken in North America (20%), Europe/South Pacific (35%), Latin America (6%), Africa/Eurasia (4%), Hill's Pet Nutrition (8%) and Corporate (27%). Total program-to-date accumulated charges for the 2012 Restructuring Program relate to initiatives undertaken in North America (14%), Europe/South Pacific (42%), Latin America (4%), Africa/Eurasia (3%), Hill's Pet Nutrition (6%) and Corporate (31%).

7

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $287 ($223 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of September 30, 2013
Employee-Related Costs	$	169
Incremental Depreciation	20
Asset Impairments	1
Other	97
Total	$	287

The majority of costs incurred since inception relate to the following projects: the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company's research and development capabilities and oral care supply chain, both in Europe; other exit costs related to office consolidation; and the restructuring of certain commercial operations in advance of implementing an overall hubbing strategy.

The following tables summarize the activity for the restructuring and implementation-related charges discussed above and the related accrual:

	Three Months Ended September 30, 2013
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at June 30, 2013	$	141		$	—		$	—	$	31		$	172
Charges	5			5			—		20			30
Cash payments	(40		)	—			—		(11		)	(51		)
Charges against assets	—			(5		)	—		—			(5		)
Foreign exchange	—			—			—		—			—
Balance at September 30, 2013	$	106		$	—		$	—	$	40		$	146

	Nine Months Ended September 30, 2013
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2012	$	84		$	—		$	—		$	5		$	89
Charges	91			20			1			86			198
Cash payments	(52		)	—			—			(51		)	(103		)
Charges against assets	(17		)	(20		)	(1		)	—			(38		)
Foreign exchange	—			—			—			—			—
Balance at September 30, 2013	$	106		$	—		$	—		$	40		$	146

Employee-related costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-related costs also include pension and other retiree benefit enhancements amounting to $17 for the nine months ended September 30, 2013, which are reflected as Charges against assets within Employee-related costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities.

Incremental depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset impairments are recorded to write

8

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

down assets held for sale or disposal to their fair value based on amounts expected to be realized. Asset impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of implementation-related charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three and nine months ended September 30, 2013 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $11 and $35, respectively, and contract termination costs of $8 and $27, respectively, directly related to the 2012 Restructuring Program. These charges were expensed as incurred. These charges, for the nine months endedSeptember 30, 2013, also included a charge for other exit costs related to office space consolidation of $24.

6. Inventories

Inventories by major class are as follows:

	September 30, 2013		December 31, 2012
Raw materials and supplies	$	340	$	362
Work-in-process	58		81
Finished goods	1,043		922
Total Inventories	$	1,441	$	1,365

7. Shareholders’ Equity

Changes in the components of Shareholders’ Equity for the nine months endedSeptember 30, 2013 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2012	$	1,466	$	818		$	(41	)	$	(14,386	)	$	16,953		$	(2,621	)	$	201
Net income												1,677						132
Other comprehensive income, net of tax															(95		)	(7		)
Dividends												(1,237		)				(108		)
Stock-based compensation expense			105
Shares issued for stock options			64						195
Shares issued for restricted stock awards			(72		)				72
Treasury stock acquired									(1,115		)
Other			(3		)	6			(2		)							5
Balance, September 30, 2013	$	1,466	$	912		$	(35	)	$	(15,236	)	$	17,393		$	(2,716	)	$	223

Accumulated other comprehensive income (loss) includes cumulative foreign currency translation losses of $1,767 and $1,609 at September 30, 2013 and December 31, 2012, respectively, and unrecognized pension and other retiree benefit costs of $997 and $1,053 at September 30, 2013 and December 31, 2012, respectively.

9

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

8. Earnings Per Share

	Three Months Ended
	September 30, 2013					September 30, 2012
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	656	928.1	$	0.71	$	654	949.8	$	0.69
Stock options and restricted stock			8.8					8.6
Diluted EPS	$	656	936.9	$	0.70	$	654	958.4	$	0.68

For the three months endedSeptember 30, 2013 and 2012, the average number of stock options and restricted stock awards that were anti-dilutive and not included in diluted earnings per share calculations were 1,956,750 and 1,214,526, respectively.

	Nine Months Ended
	September 30, 2013					September 30, 2012
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	1,677	932.5	$	1.80	$	1,874	954.8	$	1.96
Stock options and restricted stock			8.9					8.1
Diluted EPS	$	1,677	941.4	$	1.78	$	1,874	962.9	$	1.95

For the nine months endedSeptember 30, 2013 and 2012, the average number of stock options and restricted stock awards that were anti-dilutive and not included in diluted earnings per share calculations were 703,219 and 1,259,888, respectively.

As a result of the two-for-one stock split effective May 15, 2013, see Note 9, Common Stock Split, all historical per share data and number of shares were retroactively adjusted. Basic and diluted earnings per share were computed independently for each quarter and the year-to-date period presented. As a result of the stock split, changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not necessarily equal the earnings per share for the year-to-date period.

9. Common Stock Split

On March 7, 2013, the Company's Board of Directors approved a two-for-one stock split of the Company's common stock to be effected through a 100% stock dividend. The record date for the two-for-one split was the close of business on April 23, 2013, and the share distribution occurred on May 15, 2013. As a result of the split, shareholders received one additional share of Colgate common stock, par value $1.00, for each share they held as of the record date.

All per share amounts and number of shares outstanding in these Condensed Consolidated Financial Statements and Notes to the Condensed Consolidated Financial Statements are presented on a post-split basis.

In addition, the impact on the Balance Sheet as a result of the stock split was an increase of $733 to Common Stock and an offsetting reduction in Additional paid-in capital, which has been retroactively restated.

10

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

10. Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedSeptember 30, 2013 and 2012 were as follows:

	2013						2012
	Pre-tax			Net of Tax			Pre-tax			Net of Tax
Cumulative translation adjustments	$	82		$	93		$	79		$	81
Pension and other benefits:
Net actuarial gains (losses) and prior service costs arising during the period	1			1			13			8
Amortization of net actuarial losses, transition and prior service costs (1)	27			17			27			17
Retirement Plan and other retiree benefit adjustments	28			18			40			25
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	4			3			(8		)	(5		)
Reclassification of (gains) losses into net earnings on available-for-sale securities	—			—			—			—
Gains (losses) on available-for-sale securities	4			3			(8		)	(5		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	2			—			(1		)	—
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(8		)	(5		)	(3		)	(2		)
Gains (losses) on cash flow hedges	(6		)	(5		)	(4		)	(2		)
Total Other comprehensive income (loss)	$	108		$	109		$	107		$	99

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

11

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the nine months endedSeptember 30, 2013 and 2012 were as follows:

	2013						2012
	Pre-tax			Net of Tax			Pre-tax			Net of Tax
Cumulative translation adjustments	$	(170	)	$	(158	)	$	(26	)	$	(27	)
Pension and other benefits:
Net actuarial gains (losses) and prior service costs arising during the period	4			3			(19		)	(14		)
Amortization of net actuarial losses, transition and prior service costs (1)	82			53			76			49
Retirement Plan and other retiree benefit adjustments	86			56			57			35
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	(124		)	(79		)	14			9
Reclassification of (gains) losses into net earnings on available-for-sale securities (2)	133			86			—			—
Gains (losses) on available-for-sale securities	9			7			14			9
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	13			8			7			5
Reclassification of (gains) losses into net earnings on cash flow hedges (3)	(13		)	(8		)	(4		)	(2		)
Gains (losses) on cash flow hedges	—			—			3			3
Total Other comprehensive income (loss)	$	(75	)	$	(95	)	$	48		$	20

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾Represents the one-time loss related to the remeasurement of the fixed interest rate bonds in Venezuela which was recorded in Other (income) expense, net. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

⁽³⁾These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

11. Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three-month and nine-month periods ended September 30, 2013 and 2012 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended September 30,
	2013			2012			2013			2012			2013			2012
Service cost	$	6		$	4		$	6		$	6		$	3		$	2
Interest cost	22			24			8			9			8			9
ESOP offset	—			—			—			—			—			—
Expected return on plan assets	(29		)	(28		)	(7		)	(7		)	(1		)	(1		)
Amortization of transition and prior service costs (credits)	1			2			1			1			—			—
Amortization of actuarial loss	17			17			3			2			5			5
Net periodic benefit cost	$	17		$	19		$	11		$	11		$	15		$	15

12

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

	Pension Benefits												Other Retiree Benefits
	United States						International
	Nine Months Ended September 30,
	2013			2012			2013			2012			2013			2012
Service cost	$	20		$	18		$	16		$	17		$	10		$	8
Interest cost	68			73			22			26			28			30
ESOP offset	—			—			—			—			(1		)	(1		)
Expected return on plan assets	(88		)	(84		)	(19		)	(19		)	(2		)	(2		)
Amortization of transition and prior service costs (credits)	6			7			1			1			—			2
Amortization of actuarial loss	49			46			10			7			16			13
Net periodic benefit cost	$	55		$	60		$	30		$	32		$	51		$	50

For each of the nine months endedSeptember 30, 2013 and 2012, the Company made voluntary contributions of $101 to its U.S. postretirement plans.

12. Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

As a matter of course, the Company is regularly audited by the IRS and other tax authorities around the world in countries where it conducts business. In this regard, all U.S. federal income tax returns through December 31, 2007 have been audited by the IRS and there are limited matters in administrative appeals for years 2002 through 2007, the settlement of which is not expected to have a material adverse effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S., state and local income tax examinations for the years prior to 2007. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years. Estimated incremental tax payments related to potential disallowances for subsequent periods are not expected to be material.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $250 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing

13

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

In 2001, the Central Bank of Brazil sought to impose a substantial fine on the Company’s Brazilian subsidiary based on alleged foreign exchange violations in connection with the financing of the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (formerly American Home Products) (the Seller), as described in the Company’s Form 8-K dated January 10, 1995. The Company appealed the imposition of the fine to the Brazilian Monetary System Appeals Council (the Council) and, on January 30, 2007, the Council decided the appeal in the Company’s favor, dismissing the fine entirely. However, certain tax and civil proceedings related to the same acquisition of the Kolynos oral care business are still outstanding as described below.

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, are approximately $120. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process with the following results to date:

▪ In June 2005, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1996 through 1998. In March 2007, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1999 through 2001. The tax authorities appealed these decisions to the next administrative level.

▪ In August 2009, the First Taxpayers’ Council (the next and final administrative level of appeal) overruled the decisions of the First Board of Taxpayers, upholding the majority of the assessments, disallowing a portion of the assessments and remanding a portion of the assessments for further consideration by the First Board of Taxpayers.

The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers’ Council and further appeals are available within the Brazilian federal courts. The Company intends to challenge these assessments vigorously. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel and other advisors, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts.

In 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $75, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company is disputing the assessment within the internal revenue authority’s administrative appeals process. In October 2007, the Second Board of Taxpayers, which has jurisdiction over these matters, ruled in favor of the internal revenue authority. In January 2008, the Company appealed this decision, and in January 2012, a special appeals chamber of the Taxpayers’ Council denied the Company’s appeal. The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers' Council and further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the advice of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.

14

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

European Competition Matters

Since February 2006, the Company has learned that investigations relating to potential competition law violations involving the Company’s subsidiaries had been commenced by governmental authorities in a number of European countries and by the European Commission. The Company understands that substantially all of these investigations also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.

Fines have been imposed on the Company in the following matters, although, as noted below, the Company has appealed each of these fines:

▪ In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland. The Company is appealing the fine in the Swiss courts.

▪ In January 2010, Colgate’s Spanish subsidiary was fined $3 by the Spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing, which the Company contested. The fine was annulled by the Court of Appeal in July 2013. The Spanish competition law authority is appealing this judgment before the Supreme Court.

▪ In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.

▪ In December 2011, the French competition law authority found that four consumer goods companies had entered into agreements on pricing and promotion of heavy duty detergents for which Colgate’s French subsidiary was fined $46 in connection with a divested business. The Company is appealing the fine in the French courts.

▪ In March 2012, the French competition law authority found that three pet food producers, including the Company’s Hill’s France subsidiary, had violated the competition law, for which it imposed a fine of $7 on the Company’s Hill’s France subsidiary for alleged restrictions on exports from France, which the Company contested. In October 2013, the Company’s appeal was denied. The Company is evaluating whether to pursue further appeals.

Currently, formal claims of violations, or statements of objections, are pending against the Company as follows:

▪ The Belgian competition law authority has alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices on the Belgian market. The Company is in the process of responding to this statement of objections.

▪ In the second quarter of 2013, the French competition law authority issued a statement of objections alleging that the Company's French subsidiary and a number of its competitors exchanged sensitive information related to the French home care and personal care sectors. The Company has responded to this statement of objections.

An investigation is ongoing in Greece, but no formal claim of violations has been filed.

Since December 31, 2012, the following matter has been resolved:

▪ In March 2013, the German competition authority completed its investigation and no penalties were imposed against the Company or its German subsidiary.

The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The Company has undertaken a comprehensive review of its selling practices and related competition law compliance in Europe and elsewhere and, where the Company has identified a lack of compliance, it has undertaken remedial action. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate.

15

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

ERISA Matters

In October 2007, a putative class action claiming that certain aspects of the cash balance portion of the Colgate-Palmolive Company Employees’ Retirement Income Plan (the Plan) do not comply with the Employee Retirement Income Security Act was filed against the Plan and the Company in the United States District Court for the Southern District of New York. Specifically, Proesel, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al. alleges improper calculation of lump sum distributions, age discrimination and failure to satisfy minimum accrual requirements, thereby resulting in the underpayment of benefits to Plan participants.

Two other putative class actions filed earlier in 2007, Abelman, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al., in the United States District Court for the Southern District of Ohio, and Caufield v. Colgate-Palmolive Company Employees’ Retirement Income Plan, in the United States District Court for the Southern District of Indiana, both alleging improper calculation of lump sum distributions and, in the case of Abelman, claims for failure to satisfy minimum accrual requirements, were transferred to the Southern District of New York and consolidated with Proesel into one action, In re Colgate-Palmolive ERISA Litigation. The complaint in the consolidated action alleges improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements, but does not include a claim for age discrimination. The relief sought includes recalculation of benefits in unspecified amounts, pre- and post-judgment interest, injunctive relief and attorneys’ fees. In October 2013, the parties executed a settlement agreement under which the Plan would pay approximately $40 after application of certain offsets to resolve the litigation. The settlement agreement is subject to court approval. On October 9, 2013, a motion for preliminary approval of a class action settlement, class certification and appointment of class counsel was filed. The Company and the Plan intend to contest this action vigorously should the settlement not be approved and finalized.

13. Segment Information

The Company has made certain changes in its segment reporting affecting several of the geographic operating segments within its Oral, Personal and Home Care product segment. These changes have no impact on the Company's historical consolidated financial position, results of operations or cash flows.

Effective January 1, 2013, the Company realigned the geographic structure of its North America and Latin America reportable operating segments. In order to better leverage Latin America management's knowledge of emerging market consumers to accelerate growth in the region, management responsibility for the Puerto Rico and CARICOM operations was transferred from North America to Latin America management. Accordingly, commencing with the Company's financial reporting for the quarter ended March 31, 2013, the results of the Puerto Rico and CARICOM operations, which represent less than 1% of the Company's global business, were reported in the Latin America reportable operating segment. Previously, Puerto Rico and CARICOM represented approximately 4% of Net sales of North America and now represent approximately 3% of Net sales of Latin America.

In addition, given the growing importance of the Company's operations in emerging markets, effective with the quarter ended September 30, 2013, the Company is separately reporting financial information for its Asia and Africa/Eurasia operating segments. Previously, the financial information for these operating segments was aggregated into the Greater Asia/Africa reportable operating segment.

The Company has recast its historical geographic segment information to conform to the new reporting structure which results in modification to the geographic components of the Oral, Personal and Home Care segment, with no impact on historical Company results overall.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. Corporate operations include costs related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the

16

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

internal measures of segment operating performance used by the Company in order to measure the underlying performance of the business segments.

Net sales and Operating profit by segment were as follows:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2013			2012			2013			2012
Net sales
Oral, Personal and Home Care
North America	$	774		$	766		$	2,300		$	2,217
Latin America	1,251			1,276			3,747			3,777
Europe/South Pacific	880			865			2,552			2,569
Asia	627			583			1,900			1,717
Africa/Eurasia	321			314			932			918
Total Oral, Personal and Home Care	3,853			3,804			11,431			11,198
Pet Nutrition	545			528			1,628			1,601
Total Net sales	$	4,398		$	4,332		$	13,059		$	12,799
Operating profit
Oral, Personal and Home Care
North America	$	244		$	213		$	686		$	580
Latin America	358			377			1,022			1,100
Europe/South Pacific	216			198			605			560
Asia	174			164			533			474
Africa/Eurasia	65			67			192			197
Total Oral, Personal and Home Care	1,057			1,019			3,038			2,911
Pet Nutrition	138			147			410			440
Corporate	(179		)	(139		)	(784		)	(404		)
Total Operating profit	$	1,016		$	1,027		$	2,664		$	2,947

Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

For the three months ended September 30, 2013, Corporate Operating profit (loss) includes costs of $30 associated with the 2012 Restructuring Program and costs of $3 related to the sale of land in Mexico. For the nine months endedSeptember 30, 2013, Corporate Operating profit (loss) includes costs of $198 associated with 2012 Restructuring Program, a one-time $172 charge for the impact of the devaluation in Venezuela, a charge of $18 for a competition law matter in France related to the home care and personal care sectors and costs of $14 related to the sale of land in Mexico. For further information regarding the 2012 Restructuring Program, refer to Note 5, Restructuring and Related Implementation Charges. For further information regarding the Venezuela devaluation, refer to Note 15, Venezuela. For further information regarding the competition law matter in France, refer to Note 12, Contingencies. For further information regarding the sale of land in Mexico, refer to Note 4, Acquisitions and Divestitures. For the three months ended September 30, 2012, Corporate Operating profit (loss) included costs of $7 related to the sale of land in Mexico and costs of $3 associated with various business realignment and other cost-saving initiatives. For the nine months endedSeptember 30, 2012, Corporate Operating profit (loss) included costs of $20 related to the sale of land in Mexico and costs of $21 associated with various business realignment and other cost-saving initiatives.

17

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

14. Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to credit losses in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, supplier agreements, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). Foreign currency contracts consist of forward, option and swap contracts utilized to hedge a portion of the Company’s foreign currency purchases, assets and liabilities arising in the normal course of business as well as the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in the Company’s operations. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed twelve months.

18

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at September 30, 2013 and December 31, 2012:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		9/30/13		12/31/12			9/30/13		12/31/12
Interest rate swap contracts	Other current assets	$	1	$	3	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	22		41		Other liabilities	—		—
Foreign currency contracts	Other current assets	9		7		Other accruals	10		10
Foreign currency contracts	Other assets	3		13		Other liabilities	1		—
Commodity contracts	Other current assets	—		1		Other accruals	—		—
Total designated		$	35	$	65		$	11	$	10
Derivatives not designated
Foreign currency contracts	Other current assets	$	—	$	—	Other accruals	$	1	$	1
Total not designated		$	—	$	—		$	1	$	1
Total derivative instruments		$	35	$	65		$	12	$	11
Other financial instruments
Marketable securities	Other current assets	$	146	$	116
Available-for-sale securities	Other assets	676		618
Total other financial instruments		$	822	$	734

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of September 30, 2013 and December 31, 2012. The estimated fair value of the Company’s long-term debt, including the current portion, as of September 30, 2013 and December 31, 2012, was $5,465 and $5,484, respectively, and the related carrying value was $5,265 and $5,176, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

Fair value hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting loss or gain on the hedged item are recognized in current earnings. The impact of foreign currency contracts is recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest expense, net.

19

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Activity related to fair value hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013									2012
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at September 30,	$	1,568		$	1,088		$	2,656		$	944		$	1,338		$	2,282
Three months ended September 30:
Gain (loss) on derivative	(9		)	2			(7		)	(8		)	5			(3		)
Gain (loss) on hedged items	9			(2		)	7			8			(5		)	3
Nine months ended September 30:
Gain (loss) on derivative	3			(18		)	(15		)	2			12			14
Gain (loss) on hedged items	(3		)	18			15			(2		)	(12		)	(14		)

Cash flow hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (OCI) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013						2012
	Foreign Currency Contracts		Commodity Contracts		Total		Foreign Currency Contracts			Commodity Contracts		Total
Notional Value at September 30,	$	441	$	15	$	456	$	347		$	26	$	373
Three months ended September 30:
Gain (loss) recognized in OCI	2		—		2		(7		)	6		(1		)
Gain (loss) reclassified into Cost of sales	8		—		8		(1		)	4		3
Nine months ended September 30:
Gain (loss) recognized in OCI	13		—		13		(4		)	11		7
Gain (loss) reclassified into Cost of sales	12		1		13		—			4		4

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.

Net investment hedges

The Company has designated certain foreign currency forward contracts, option contracts and foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Currency translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

20

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Activity related to net investment hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013									2012
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at September 30,	$	557		$	238		$	795		$	527		$	296		$	823
Three months ended September 30:
Gain (loss) on instruments	(18		)	(9		)	(27		)	(6		)	(2		)	(8		)
Gain (loss) on hedged items	18			9			27			8			2			10
Nine months ended September 30:
Gain (loss) on instruments	(8		)	—			(8		)	2			2			4
Gain (loss) on hedged items	9			—			9			(5		)	(2		)	(7		)

Derivatives Not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. 

Activity related to these contracts during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013			2012
	Cross-currency Swap			Cross-currency Swap
Notional Value at September 30,	$	96		$	96
Three months ended September 30:
Gain (loss) on instrument	(6		)	(3		)
Gain (loss) on hedged item	6			3
Nine months ended September 30:
Gain (loss) on instrument	—			(4		)
Gain (loss) on hedged item	—			4

Other Financial Instruments

Other financial instruments are classified as Other current assets or Other assets.

Other financial instruments classified as Other current assets include marketable securities, which consist of bank deposits of $122 with original maturities greater than 90 days (Level 1 valuation) and the current portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $24. The long-term portion of these bonds in the amount of $676 is included in Other assets.

Through its subsidiary in Venezuela, the Company is invested in U.S. dollar-linked, devaluation-protected bonds and fixed interest rate bonds, both of which are issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of September 30, 2013, the U.S. dollar-linked, devaluation protected bonds and the fixed interest rate bonds had fair market values of $257 and $443, respectively. These investments are considered available-for-sale securities and, as noted above, $24 is included in Other current assets and $676 is included in Other assets.

21

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following table presents a reconciliation of the fair value of the Venezuelan bonds for the nine months endedSeptember 30, 2013 and 2012:

	2013			2012
Beginning balance as of January 1,	$	642		$	236
Unrealized gain (loss) on investment	(124		)	14
Purchases and sales during the period	182			373
Ending balance as of September 30,	$	700		$	623

The Unrealized loss on investment consisted primarily of a one-time loss of $133 in the first quarter of 2013 related to the remeasurement of the fixed interest rate bonds at February 9, 2013, the date of the devaluation. For further information regarding Venezuela and the devaluation, refer to Note 15, Venezuela below.

15. Venezuela

Venezuela has been designated hyper-inflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (“CP Venezuela”) is the U.S. dollar and Venezuelan currency fluctuations are reported in income.

The Venezuelan government devalued its currency effective February 9, 2013. As a result of the devaluation the official exchange rate changed from 4.30 to 6.30 Venezuela bolivares fuerte per dollar. The Company incurred a one-time, pretax loss of $172 ($111 aftertax loss) in the first quarter of 2013 related to the remeasurement of the net monetary assets included in the local balance sheet at the date of the devaluation. The impact of this one-time aftertax loss of $111 on diluted earnings per common share was $0.12 for the nine months endedSeptember 30, 2013. The Company remeasured the financial statements of CP Venezuela at the rate at which it currently expects to remit future dividends, which is 6.30. As the local currency operations in Venezuela translated into fewer U.S. dollars, this had and will continue to have an ongoing adverse effect on the Company's reported results.

For the nine months endedSeptember 30, 2013, CP Venezuela represented approximately 4% of the Company’s consolidated Net sales. At September 30, 2013, CP Venezuela’s bolivar fuerte-denominated net monetary asset position, which would be subject to remeasurement in the event of a further devaluation, was approximately $530. This amount does not include $257 of devaluation-protected bonds issued by the Venezuelan government, as these bonds provide protection against devaluations by adjusting the amount of bolivares fuerte received at maturity for any devaluation subsequent to issuance.

22

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Executive Overview and Outlook

Colgate-Palmolive Company seeks to deliver strong, consistent business results and superior shareholder returns by providing consumers globally with products that make their lives healthier and more enjoyable.

To this end, the Company is tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, the Company follows a closely defined business strategy to develop and increase market leadership positions in key product categories. These product categories are prioritized based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable long-term growth.

Operationally, the Company is organized along geographic lines with management teams having responsibility for the business and financial results in each region. The Company competes in more than 200 countries and territories worldwide with established businesses in all regions contributing to the Company’s sales and profitability. Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce the Company’s exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care segment is operated through five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia, all of which sell to a variety of retail and wholesale customers and distributors. The Company, through Hill’s Pet Nutrition, also competes on a worldwide basis in the pet nutrition market, selling its products principally through specialty pet retailers and the veterinary profession.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include market share, net sales (including volume, pricing and foreign exchange components), organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments), gross profit margin, operating profit, net income and earnings per share, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. The monitoring of these indicators and the Company’s Code of Conduct and corporate governance practices help to maintain business health and strong internal controls.

To achieve its business and financial objectives, the Company focuses the organization on initiatives to drive and fund growth. The Company seeks to capture significant opportunities for growth by identifying and meeting consumer needs within its core categories, through its focus on innovation and the deployment of valuable consumer and shopper insights in the development of successful new products regionally, which are then rolled out on a global basis. To enhance these efforts, the Company has developed key initiatives to build strong relationships with consumers, dental and veterinary professionals and retail customers. Growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for the Company’s products.

The investments needed to support growth are developed through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as the Company’s funding-the-growth initiatives, the Company seeks to become even more effective and efficient throughout its businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses and distribution and logistics and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification. The Company also continues to prioritize its investments toward its higher margin businesses, specifically Oral Care, Personal Care and Pet Nutrition.

With approximately 80% of its Net sales generated outside the Unites States, the Company is exposed to changes in economic conditions and foreign currency exchange rates, as well as political uncertainty in some countries, all of which could impact future operating results. For example, as discussed in detail below, the operating environment in Venezuela is challenging, with economic uncertainty fueled by currency devaluations and high inflation and governmental restrictions in the form of import authorization controls, currency exchange controls, price controls and the possibility of expropriation of property or other resources.

In particular, the Company has been and will continue to be impacted as a result of the significant devaluations of the Venezuelan bolivar fuerte that occurred in 2010 and in February 2013, described in Note 15, Venezuela to the Condensed

23

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Consolidated Financial Statements. Effective February 9, 2013, the Venezuelan government devalued its currency and the official exchange rate changed from 4.30 to 6.30 Venezuela bolivares fuerte per dollar. The Company incurred a one-time, pretax loss of $172 ($111 aftertax loss), in the first quarter of 2013 related to the remeasurement of the net monetary assets in the local balance sheet at the date of the devaluation. The Company remeasured the financial statements of its Venezuelan subsidiary ("CP Venezuela") at the rate at which it currently expects to remit future dividends, which is 6.30. As the local currency operations in Venezuela translated into fewer U.S. dollars, this had and will continue to have an ongoing adverse effect on the Company's reported results.

In addition, the Venezuelan government continues to impose import authorization controls, currency exchange and payment controls and price controls. CP Venezuela continues to have limited access to U.S. dollars from the government (CADIVI), currently only for imported goods. The timing of receipt of these funds is at CADIVI's discretion. CP Venezuela funds its requirements for imported goods primarily through a combination of U.S. dollars obtained from CADIVI, intercompany borrowings and the use of financial and other intermediaries and, to a lesser extent, with existing U.S. dollar cash balances, which were obtained previously through parallel market transactions and through the prior liquidation of its U.S. dollar-denominated bond portfolio. In the second quarter of 2013, the Venezuelan government introduced a new currency market known as SICAD (Supplementary System for the Administration of Foreign Currency), which replaces the former SITME market and is expected to be accessible to the Company. Price controls, which became effective on April 1, 2012, affect most products in CP Venezuela’s portfolio and thereby further restrict the Company’s ability to implement price increases, which had been one of the key mechanisms to offset the effects of continuing high inflation and the impact of currency devaluation. At times, production at CP Venezuela has also been negatively impacted by labor issues within the country.

The Company’s business in Venezuela, and the Company’s ability to repatriate its earnings, continue to be negatively affected by these difficult conditions and would be further negatively affected by additional devaluations or the imposition of additional or more stringent controls on foreign currency exchange, pricing or imports or other governmental actions or continued or increased labor unrest. At September 30, 2013, CP Venezuela's local currency-denominated net monetary asset position, which would be subject to remeasurement in the event of a further devaluation, was approximately $530 as compared to approximately $520 at December 31, 2012. For the nine months ended September 30, 2013, CP Venezuela represented approximately 4% of the Company's consolidated Net sales and approximately 3% of the Company's consolidated Operating profit excluding the impact of the one-time Venezuela devaluation charge and charges related to 2012 Restructuring Program, the competition law matter in France related to the home care and personal care sectors and the sale of land in Mexico (discussed below). The Company continues to actively manage its investment in and exposure to Venezuela.

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program (the 2012 Restructuring Program) for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses. Implementation of the 2012 Restructuring Program, which is expected to be substantially completed by December 31, 2016, is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax). Savings, substantially all of which are expected to increase future cash flows, are projected to be in the range of $365 to $435 pretax ($275 to $325 aftertax) annually by the fourth year of the program. For more information regarding the 2012 Restructuring Program, see “Restructuring and Related Implementation Charges” below.

For the three and nine months ended September 30, 2013, the Company incurred aftertax costs of $22 and $153, respectively, associated with the 2012 Restructuring Program and aftertax costs of $2 and $9, respectively, related to the sale of land in Mexico.

On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. The Company is re-investing these payments to relocate its soap production to a new state-of-the-art facility to be constructed at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. As a result, the Company expects to make capital improvements and incur costs to exit the site through 2014. These exit costs will primarily be related to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready.

On July 29, 2011, in connection with the acquisition of the Sanex personal care business from Unilever, N.V. and Unilever PLC (together "Unilever"), Colgate sold its non-core laundry detergent business in Colombia to Unilever for $215 resulting in a pretax gain of $207 ($135 aftertax gain). In 2011, this gain was more than offset by pretax costs of $224 ($177 aftertax costs)

24

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

associated with the implementation of business realignment and other cost-saving initiatives, the sale of land in Mexico and a competition law matter in France related to a divested detergent business as discussed in Note 12, Contingencies to the Condensed Consolidated Financial Statements. The business realignment and other cost-saving initiatives include the integration of Sanex, the right-sizing of the Colombia business and the closing of an oral care facility in Mississauga, Canada and a Hill’s facility in Los Angeles, California.

Looking forward, the Company expects global macroeconomic and market conditions to remain highly challenging. While the global marketplace in which the Company operates has always been highly competitive, the Company continues to experience heightened competitive activity in certain markets from other large multinational companies, some of which have greater resources than the Company does. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion. Additionally, the Company continues to experience volatile foreign currency fluctuations and high commodity costs. While the Company has taken, and will continue to take, measures to mitigate the effect of these conditions, should they persist, they could adversely affect the Company’s future results.

The Company believes it is well prepared to meet the challenges ahead due to its strong financial condition, experience operating in challenging environments and continued focus on the Company’s strategic initiatives: engaging to build our brands; innovation for growth; effectiveness and efficiency; and leading to win. This focus, together with the strength of the Company’s global brand names, its broad international presence in both mature and emerging markets and initiatives such as the 2012 Restructuring Program, should position the Company well to increase shareholder value over the long-term.

Results of Operations

Three Months

Worldwide Net sales were $4,398 in the third quarter of 2013, up 1.5% from the third quarter of 2012, as volume growth of 5.0% and net selling price increases of 1.0% were partially offset by negative foreign exchange of 4.5%. Organic sales (Net sales excluding foreign exchange and acquisitions and divestments), a non-GAAP financial measure as discussed below, increased 6.0% in the third quarter of 2013.

Net sales in the Oral, Personal and Home Care segment were $3,853 in the third quarter of 2013, up 1.5% from the third quarter of 2012, as volume growth of 5.0% and net selling price increases of 1.0% were partially offset by negative foreign exchange of 4.5%. Organic sales in the Oral, Personal and Home Care segment increased 6.0% in the third quarter of 2013.

The Company's share of the global toothpaste market was 45.0% on a year-to-date basis and its share of the global manual toothbrush market was 33.4% on a year-to-date basis. Year-to-date market shares in toothpaste were up in Europe/South Pacific and Asia, flat in Africa/Eurasia and down in North America and Latin America versus the year ago period. In the manual toothbrush category, year-to-date market shares were up in Latin America, North America, Europe/South Pacific and Africa/Eurasia and down in Asia versus the year ago period. For additional information regarding market shares, see “Market Share Information” below.

Net sales for Hill’s Pet Nutrition increased 3.0% in the third quarter of 2013 to $545, as volume growth of 3.0% and net selling price increases of 3.0% were partially offset by negative foreign exchange of 3.0%. Organic sales in Hill’s Pet Nutrition increased 6.0% in the third quarter of 2013. 

Gross Profit/Margin

Worldwide Gross profit increased 2% to $2,585 in the third quarter of 2013 from $2,529 in the third quarter of 2012. 

Gross profit in the third quarter of 2013 included costs related to the 2012 Restructuring Program. Gross profit in both periods included costs related to the sale of land in Mexico, while Gross profit in the third quarter of 2012 also included costs associated with various business realignment and other cost-saving initiatives. Excluding the items described above in both periods, Gross profit increased to $2,596 in the third quarter of 2013 from $2,537 in the third quarter of 2012, primarily due to sales growth ($40) and gross profit margin expansion ($19).

25

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Worldwide Gross profit margin increased to 58.8% in the third quarter of 2013 from 58.4% in the third quarter of 2012.  Excluding the items described above, Gross profit margin increased by 40 bps to 59.0% in the third quarter of 2013 from 58.6% in the third quarter of 2012 as higher pricing (40 bps) and cost savings from the Company's funding-the-growth initiatives (240 bps) more than offset higher raw and packaging material costs (220 bps), which included foreign exchange transaction costs.

	Three Months Ended September 30,
	2013		2012
Gross profit, GAAP	$	2,585	$	2,529
2012 Restructuring Program	8		—
Costs related to the sale of land in Mexico	3		7
Business realignment and other cost-saving initiatives	—		1
Gross profit, non-GAAP	$	2,596	$	2,537

	Three Months Ended September 30,
	2013		2012		Basis Point Change
Gross profit margin, GAAP	58.8	%	58.4	%	40
2012 Restructuring Program	0.2	%	—
Costs related to the sale of land in Mexico	—		0.2	%
Business realignment and other cost-saving initiatives	—		—
Gross profit margin, non-GAAP	59.0	%	58.6	%	40

Selling, General and Administrative expenses

Selling, general and administrative expenses increased 3% to $1,549 in the third quarter of 2013 from $1,501 in the third quarter of 2012. 

Selling, general and administrative expenses in the third quarter of 2013 included costs of $9 associated with the 2012 Restructuring Program. Selling, general and administrative expenses in the third quarter of 2012 included costs of $2 associated with various business realignment and other cost-saving initiatives. Excluding the impact of costs associated with the 2012 Restructuring Program in the third quarter of 2013 and various business realignment and other cost-saving initiatives in the third quarter of 2012, Selling, general and administrative expenses increased to $1,540 in the third quarter of 2013 from $1,499 in the third quarter of 2012, reflecting higher overhead expenses of $16 and increased advertising investment of $25.

Selling, general and administrative expenses as a percentage of Net sales increased to 35.2% in the third quarter of 2013 from 34.6% in the third quarter of 2012. Excluding the impact of costs associated with the 2012 Restructuring Program in the third quarter of 2013, Selling, general and administrative expenses as a percentage of Net sales were 35.0%, an increase of 40 bps as compared to the third quarter of 2012. This increase was a result of increased advertising investment (40 bps) as a percentage of Net sales. In the third quarter of 2013, advertising investment increased 5.5% to $478, as compared with $453 in the third quarter of 2012, and increased as a percentage of Net sales to 10.9% in the third quarter of 2013 from 10.5% in the third quarter of 2012.

26

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

	Three Months Ended September 30,
	2013			2012
Selling, general and administrative expenses, GAAP	$	1,549		$	1,501
2012 Restructuring Program	(9		)	—
Business realignment and other cost-saving initiatives	—			(2		)
Selling, general and administrative expenses, non-GAAP	$	1,540		$	1,499

	Three Months Ended September 30,
	2013		2012		Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP	35.2	%	34.6	%	60
2012 Restructuring Program	(0.2	)%	—
Business realignment and other cost-saving initiatives	—		—
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP	35.0	%	34.6	%	40

Other (income) expense, net

Other (income) expense, net was $20 in the third quarter of 2013, as compared to $1 in the third quarter of 2012. Other (income) expense in the third quarter of 2013 included charges of $13 associated with the 2012 Restructuring Program. Excluding these charges, Other (income) expense, net increased to $7 in the third quarter of 2013 from $1 in the third quarter of 2012.

	Three Months Ended September 30,
	2013			2012
Other (income) expense, net, GAAP	$	20		$	1
2012 Restructuring Program	(13		)	—
Other (income) expense, net, non-GAAP	$	7		$	1

Operating Profit

Operating profit decreased 1% to $1,016 in the third quarter of 2013 from $1,027 in the third quarter of 2012.

Operating profit in the third quarter of 2013 included charges of $30 associated with the 2012 Restructuring Program and costs of $3 related to the sale of land in Mexico. Operating profit in the third quarter of 2012 included costs of $7 related to the sale of land in Mexico and costs of $3 associated with various business realignment and other cost-saving initiatives. Excluding the items described above in both periods, Operating profit increased 1% to $1,049 in the third quarter of 2013, as compared to $1,037 in the third quarter of 2012, primarily due to sales growth and higher Gross profit margin.

Operating profit margin was 23.1% in the third quarter of 2013, a decrease of 60 bps compared to the third quarter of 2012. Excluding the items described above in both periods, Operating profit margin remained flat in the third quarter of 2013 as compared to the third quarter of 2012, as an increase in Gross profit margin (40 bps) was offset by an increase in Selling, general and administrative expenses as a percentage of Net sales, due to increased advertising investment (40 bps).

27

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

	Three Months Ended September 30,
	2013		2012		% Change
Operating profit, GAAP	$	1,016	$	1,027	(1	)%
2012 Restructuring Program	30		—
Costs related to the sale of land in Mexico	3		7
Business realignment and other cost-saving initiatives	—		3
Operating profit, non-GAAP	$	1,049	$	1,037	1	%

	Three Months Ended September 30,
	2013		2012		Basis Point Change
Operating profit margin, GAAP	23.1	%	23.7	%	(60	)
2012 Restructuring Program	0.7	%	—
Costs related to the sale of land in Mexico	0.1	%	0.1	%
Business realignment and other cost-saving initiatives	—		0.1	%
Operating profit margin, non-GAAP	23.9	%	23.9	%	—

Interest expense, net

Interest expense, net decreased to $0 for the three months ended September 30, 2013 as compared with $4 in the comparable period of 2012, primarily due to an increase in interest income on investments held outside the U.S.

Net income attributable to Colgate-Palmolive Company and Earnings per share

Net income attributable to Colgate-Palmolive Company for the third quarter of 2013 increased to $656 from $654 in the third quarter of 2012, and earnings per common share on a diluted basis increased to $0.70 per share in the third quarter of 2013 from $0.68 per share in the third quarter of 2012. Net income attributable to Colgate-Palmolive Company in the third quarter of 2013 included charges of $22 associated with the 2012 Restructuring Program and costs of $2 related to the sale of land in Mexico. Net income attributable to Colgate-Palmolive Company in the third quarter of 2012 included costs of $5 related to the sale of land in Mexico and costs of $2 associated with various business realignment and other cost-saving initiatives.

Excluding the items described above, Net income attributable to Colgate-Palmolive Company in the third quarter of 2013 increased 3% to $680 and earnings per share on a diluted basis increased 6% to $0.73.

	Three Months Ended September 30,
	2013		2012		% Change
Net income attributable to Colgate-Palmolive Company, GAAP	$	656	$	654	—	%
2012 Restructuring Program	22		—
Costs related to the sale of land in Mexico	2		5
Business realignment and other cost-saving initiatives	—		2
Net income attributable to Colgate-Palmolive Company, non-GAAP	$	680	$	661	3	%

28

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

	Three Months Ended September 30,
	2013		2012		% Change
Earnings per common share, diluted, GAAP	$	0.70	$	0.68	3	%
2012 Restructuring Program	0.02		—
Costs related to the sale of land in Mexico	0.01		0.01
Earnings per common share, diluted, non-GAAP	$	0.73	$	0.69	6	%

Net Sales and Operating Profit by Segment

Oral, Personal and Home Care

Effective January 1, 2013, the Company realigned the geographic structure of its North America and Latin America reportable operating segments. In order to better leverage Latin America management's knowledge of emerging market consumers to accelerate growth in the region, management responsibility for the Puerto Rico and CARICOM operations was transferred from North America to Latin America management. Accordingly, commencing with the Company's financial reporting for the quarter ended March 31, 2013, the results of the Puerto Rico and CARICOM operations, which represent less than 1% of the Company's global business were reported in the Latin America reportable operating segment. Previously, Puerto Rico and CARICOM represented approximately 4% of Net sales of North America and now represent approximately 3% of Net sales of Latin America.

In addition, given the growing importance of the Company's operations in emerging markets, effective with the quarter ended September 30, 2013, the Company is separately reporting financial information for its Asia and Africa/Eurasia operating segments. Previously, the financial information for these operating segments was aggregated into the Greater Asia/Africa reportable operating segment.

The Company has recast its historical geographic segment information to conform to the new reporting structure which results in modification to the geographic components of the Oral, Personal and Home Care segment, with no impact on historical Company results overall.

North America

	Three Months Ended September 30,
	2013			2012			Change
Net sales	$	774		$	766		1.0	%
Operating profit	$	244		$	213		15	%
% of Net sales	31.5		%	27.8		%	370	bps

Net sales in North America increased 1.0% in the third quarter of 2013 to $774, driven by volume growth of 1.5% as net selling prices were flat and foreign exchange was negative 0.5%. Organic sales in North America increased 1.5% in the third quarter of 2013.

The increase in organic sales in North America in the third quarter of 2013 versus the third quarter of 2012 was due to an increase in Oral Care sales with strong sales in the mouthwash category and an increase in Home Care sales with the hand dish and fabric softener categories contributing to growth.

Operating profit in North America increased 15% in the third quarter of 2013 to $244, or 370 bps to 31.5% of Net sales. This increase in Operating profit was primarily due to an increase in Gross profit (160 bps) and a decrease in Selling, general and administrative expenses (230 bps), both as a percentage of Net sales. This increase in Gross profit was mainly driven by cost savings from the Company’s funding-the-growth initiatives (250 bps). This decrease in Selling, general and administrative expenses was due to lower overhead costs (90 bps) and decreased advertising (130 bps), the latter due to the timing of new product launches.

29

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Latin America

	Three Months Ended September 30,
	2013			2012			Change
Net sales	$	1,251		$	1,276		(2.0	)	%
Operating profit	$	358		$	377		(5	)	%
% of Net sales	28.6		%	29.5		%	(90	)	bps

Net sales in Latin America decreased 2.0% to $1,251 in the third quarter of 2013. Volume growth of 5.5% and net selling price increases of 3.5% were more than offset by negative foreign exchange of 11.0%. Organic sales in Latin America increased 9.5% in the third quarter of 2013. Volume gains were led by Brazil,Venezuela, Central America and Mexico.

The increase in organic sales in Latin America in the third quarter of 2013 versus the third quarter 2012 was driven by an increase in Oral Care sales with the toothpaste, manual toothbrush and mouthwash categories all contributing to growth. Personal Care also contributed to organic sales growth due to strong sales in the bar soap category.

Operating profit in Latin America decreased 5% in the third quarter of 2013 to $358, or 90 bps to 28.6% of Net sales. This decrease in Operating profit was primarily due to a decrease in Gross profit (100 bps), which was partially offset by a decrease in Selling, general and administrative expenses (20 bps), both as a percentage of Net sales. This decrease in Gross profit was due to higher costs (510 bps), primarily in Venezuela, which were partially offset by cost savings from the Company’s funding-the-growth initiatives (260 bps) and the benefits of pricing as noted above. This decrease in Selling, general and administrative expenses was driven by lower overhead expenses (50 bps), which were partially offset by increased advertising investment (40 bps).

Europe/South Pacific

	Three Months Ended September 30,
	2013			2012			Change
Net sales	$	880		$	865		1.5	%
Operating profit	$	216		$	198		9	%
% of Net sales	24.5		%	22.9		%	160	bps

Net sales in Europe/South Pacific increased 1.5% in the third quarter of 2013 to $880. Volume growth of 2.0% and positive foreign exchange of 1.0% were partially offset by net selling price decreases of 1.5%. Organic sales in Europe/South Pacific increased 1.0% in the third quarter of 2013. Volume gains were led by Australia, Poland and Germany.

The increase in organic sales in Europe/South Pacific in the third quarter of 2013 versus the third quarter of 2012 was due to higher Oral Care sales which were partially offset by declines in sales in the Personal Care and Home Care categories. The toothpaste, manual toothbrush and mouthwash categories all contributed to the increase in Oral Care sales. Declines in sales in the body wash and underarm protection categories contributed to the decrease in Personal Care sales. The decrease in Home Care sales was due to sales declines in the liquid cleaners category.

Operating profit in Europe/South Pacific increased 9% in the third quarter of 2013 to $216, or 160 bps to 24.5% of Net sales. This increase in Operating profit was primarily due to an increase in Gross profit (220 bps), which was partially offset by an increase in Selling, general and administrative expenses (30 bps), both as a percentage of Net sales. This increase in Gross profit was primarily driven by savings from the Company’s funding-the-growth initiatives (250 bps), which were partially offset by lower pricing as noted above. This increase in Selling, general and administrative expenses was driven by increased advertising investment (110 bps), which was partially offset by lower overhead costs (80 bps).

30

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Asia

	Three Months Ended September 30,
	2013			2012			Change
Net sales	$	627		$	583		7.5		%
Operating profit	$	174		$	164		6		%
% of Net sales	27.8		%	28.1		%	(30	)	bps

Net sales in Asia increased 7.5% in the third quarter of 2013 to $627 driven by volume growth of 11.0%, which was partially offset by net selling price decreases of 0.5% and negative foreign exchange of 3.0%. Organic sales in Asia grew 10.5% in the third quarter of 2013. Volume gains were led by the Greater China region, India and the Philippines.

The increase in organic sales in the third quarter of 2013 versus the third quarter of 2012 was driven by an increase in Oral Care sales with the toothpaste and manual toothbrush categories contributing to growth. Personal Care sales also contributed to growth behind sales gains in the shampoo category.

Operating profit in Asia increased 6% in the third quarter of 2013 to $174, while as a percentage of Net sales it decreased 30 bps to 27.8%. This decrease in Operating profit as a percentage of Net sales was primarily due to an increase in Selling, general and administrative expenses (180 bps), which was partially offset by an increase in Gross profit (150 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (240 bps), partially offset by higher raw and packaging material costs (50 bps), which included foreign exchange transaction costs, and lower pricing as noted above. This increase in Selling, general and administrative expenses was driven by increased advertising investment (150 bps) and increased investment in customer development initiatives (30 bps).

Africa/Eurasia

	Three Months Ended September 30,
	2013			2012			Change
Net sales	$	321		$	314		2.0		%
Operating profit	$	65		$	67		(3	)	%
% of Net sales	20.2		%	21.3		%	(110	)	bps

Net sales in Africa/Eurasia increased 2.0% in the third quarter of 2013 to $321. Volume growth of 7.5% and net selling price increases of 1.0% were partially offset by negative foreign exchange of 6.5%. Organic sales in Africa/Eurasia grew 8.5% in the third quarter of 2013. Volume gains were led by Turkey, the Sub Saharan Africa region, the Central Asia/Caucasus region and Russia.

The increase in organic sales in the third quarter of 2013 versus the third quarter of 2012 was driven by an increase in Oral Care sales due to strong sales in the toothpaste category. Personal Care sales also contributed to growth behind sales gains in the body wash category.

Operating profit in Africa/Eurasia decreased 3% in the third quarter of 2013 to $65, or 110 bps to 20.2% of Net sales, as an increase in Gross profit (50 bps) was more than offset by an increase in Selling, general and administrative expenses (150 bps), both as a percentage of Net sales. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (110 bps) and the benefits of pricing as noted above, partially offset by higher raw and packaging material costs (120 bps), which included foreign exchange transaction costs. This increase in Selling, general and administrative expenses was primarily due to higher overhead costs (170 bps).

31

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Hill’s Pet Nutrition

	Three Months Ended September 30,
	2013			2012			Change
Net sales	$	545		$	528		3.0		%
Operating profit	$	138		$	147		(6	)	%
% of Net sales	25.3		%	27.8		%	(250	)	bps

Net sales for Hill’s Pet Nutrition increased 3.0% in the third quarter of 2013 to $545, driven by volume growth of 3.0% and net selling price increases of 3.0%, which were partially offset by negative foreign exchange of 3.0%. Organic sales in Hill’s Pet Nutrition increased 6.0% in the third quarter of 2013. Volume gains were led by the United States and Russia and were partially offset by volume declines in Japan. The volume decline in Japan is attributable to a continued contraction in the market as well as heightened competition.

The increase in organic sales in the third quarter of 2013 versus the third quarter of 2012 was driven by continued growth in the Prescription Diet Metabolic category, the Science Diet dry products, which were reformulated and relaunched earlier this year to retain and attract consumers to the Advanced Nutrition category and the recently launched line of products under the Ideal Balance brand to directly compete in the Naturals category.

Operating profit in Hill’s Pet Nutrition decreased 6% in the third quarter of 2013 to $138, or 250 bps to 25.3% of Net sales. This decrease in Operating profit was primarily due to a decrease in Gross profit (240 bps) and an increase in Selling, general and administrative expenses (60 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily driven by higher raw and packaging material costs (500 bps), due in part to formulation changes and foreign exchange transaction costs, which were partially offset by cost savings from the Company’s funding-the-growth initiatives (210 bps) and the benefit of pricing as noted above. This increase in Selling, general and administrative expenses was due to increased investment in customer development initiatives (20 bps) and increased advertising investment (30 bps).

Corporate

	Three Months Ended September 30,
	2013			2012			Change
Operating profit (loss)	$	(179	)	$	(139	)	29	%

Operating profit (loss) related to Corporate was ($179) in the third quarter of 2013 as compared to ($139) in the third quarter of 2012. In the third quarter of 2013, Corporate Operating profit (loss) included charges of $30 associated with the 2012 Restructuring Program and costs of $3 related to the sale of land in Mexico. In the third quarter of 2012, Corporate Operating profit (loss) included the impact of costs of $7 related to the sale of land in Mexico and costs of $3 associated with various business realignment and other cost-saving initiatives.

Nine Months

Worldwide Net sales were $13,059 in the first nine months of 2013, up 2.0% from the first nine months of 2012, as volume growth of 4.5% and net selling price increases of 1.0% were partially offset by negative foreign exchange of 3.5%. Organic sales increased 5.5% in the first nine months of 2013.

Net sales in the Oral, Personal and Home Care segment were $11,431 in the first nine months of 2013, up 2.0% from the first nine months of 2012, as volume growth of 4.5% and net selling price increases of 1.0% were partially offset by negative foreign exchange of 3.5%. Organic sales in the Oral, Personal and Home Care segment increased 6.0% in the first nine months of 2013.

32

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

The increase in organic sales in the first nine months of 2013, versus the first nine months of 2012 was driven by an increase in Oral Care sales with the toothpaste, manual toothbrush and mouthwash categories all contributing to growth. Personal Care sales also contributed to growth behind sales gains in the bar soap category.

Net sales and Operating profit by segment

Net sales and Operating profit by segment were as follows:

	Nine Months Ended September 30,
	2013			2012
Net sales
Oral, Personal and Home Care
North America	$	2,300		$	2,217
Latin America	3,747			3,777
Europe/South Pacific	2,552			2,569
Asia	1,900			1,717
Africa/Eurasia	932			918
Total Oral, Personal and Home Care	11,431			11,198
Pet Nutrition	1,628			1,601
Total Net sales	$	13,059		$	12,799
Operating profit
Oral, Personal and Home Care
North America	$	686		$	580
Latin America	1,022			1,100
Europe/South Pacific	605			560
Asia	533			474
Africa/Eurasia	192			197
Total Oral, Personal and Home Care	3,038			2,911
Pet Nutrition	410			440
Corporate	(784		)	(404		)
Total Operating profit	$	2,664		$	2,947

Within the Oral, Personal and Home Care segment, North America Net sales increased 3.5%, driven by volume growth of 3.5% and net selling price increases of 0.5% which were partially offset by negative foreign exchange of 0.5%. Organic sales in North America increased 4.0%. Latin America Net sales decreased 1.0%, as volume growth of 4.5% and net selling price increases of 3.5% were more than offset by negative foreign exchange of 9.0%, primarily due to the devaluation of the Venezuelan bolivar fuerte. Organic sales in Latin America increased 8.5%. Europe/South Pacific Net sales decreased 0.5% as volume growth of 1.0% was more than offset by net selling price decreases of 1.5% and foreign exchange was flat. Organic sales in Europe/South Pacific were flat. Asia Net sales increased 10.5% as volume growth of 11.0% and net selling price increases of 0.5% were partially offset by negative foreign exchange of 1.0%. Organic sales in Asia increased 11.5%. Africa/Eurasia Net sales increased 1.5% driven by volume growth of 9.0%, which was partially offset by net selling price decreases of 2.0% and negative foreign exchange of 5.5%. Organic sales in Africa/Eurasia increased 7.0% .

Net sales for the Hill’s Pet Nutrition segment increased 1.5% as volume growth of 1.0% and net selling price increases of 3.0% were partially offset by negative foreign exchange of 2.5%. Organic sales increased 4.0% in the first nine months of 2013.

33

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

In the first nine months of 2013, Operating profit (loss) related to Corporate was ($784) as compared to ($404) in the first nine months of 2012. In the first nine months of 2013, Corporate Operating profit (loss) included charges of $198 associated with the 2012 Restructuring Program, a one-time $172 charge for the impact of the devaluation in Venezuela, a charge of $18 for a competition law matter in France related to the home care and personal care sectors and costs of $14 related to the sale of land in Mexico. In the first nine months of 2012, Corporate Operating profit (loss) included the impact of costs of $20 related to the sale of land in Mexico and costs of $21 associated with various business realignment and other cost-saving initiatives.

Gross Profit/Margin

Worldwide Gross profit increased 3% to $7,634 in the first nine months of 2013 from $7,427 in the first nine months of 2012. 

Gross profit in the first nine months of 2013 included the impact of costs related to the 2012 Restructuring Program, while Gross profit in both periods included costs related to the sale of land in Mexico. Gross profit in the first nine months of 2012 also included costs associated with various business realignment and other cost-saving initiatives. Excluding the items described above, Gross profit increased to $7,671 in the first nine months of 2013 from $7,452 in the first nine months of 2012, primarily due to sales growth ($153) and gross profit margin expansion ($66).

Worldwide Gross profit margin increased to 58.5% in the first nine months of 2013 from 58.0% in the first nine months of 2012. Excluding the items described above, Gross profit margin increased by 50 bps to 58.7% in the first nine months of 2013 from 58.2% in the first nine months of 2012. The increase in Gross profit margin was primarily due to cost savings from the Company’s funding-the-growth initiatives (190 bps) and higher pricing (40 bps), which were partially offset by higher raw and packaging material costs (190 bps), which included foreign exchange transaction costs.

	Nine Months Ended September 30,
	2013		2012
Gross profit, GAAP	$	7,634	$	7,427
2012 Restructuring Program	26		—
Costs related to the sale of land in Mexico	11		20
Business realignment and other cost-saving initiatives	—		5
Gross profit, non-GAAP	$	7,671	$	7,452

	Nine Months Ended September 30,
	2013		2012		Basis Point Change
Gross profit margin, GAAP	58.5	%	58.0	%	50
2012 Restructuring Program	0.2	%	—
Costs related to the sale of land in Mexico	—		0.2	%
Gross profit margin, non-GAAP	58.7	%	58.2	%	50

Selling, General and Administrative expenses

Selling, general and administrative expenses increased 4% to $4,611 in the first nine months of 2013 from $4,443 in the first nine months of 2012.

Excluding the impact of costs associated with the 2012 Restructuring Program in the first nine months of 2013 and various business realignment and other cost-saving initiatives in the first nine months of 2012, Selling, general and administrative expenses increased to $4,580 in the first nine months of 2013, reflecting higher overhead expenses of $63 and increased advertising investment of $88.

34

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Selling, general and administrative expenses as a percentage of Net sales increased to 35.3% in the first nine months of 2013 from 34.7% in the first nine months of 2012. Excluding the impact of charges associated with the 2012 Restructuring Program in the first nine months of 2013 and various business realignment and other cost-saving initiatives in the first nine months of 2012, Selling, general and administrative expenses as a percentage of Net sales were 35.1%, an increase of 50 bps as compared to the first nine months of 2012. This increase was a result of increased advertising investment (50 bps) as a percentage of Net sales. In the first nine months of 2013, advertising investment increased 6.5% to $1,446, as compared with $1,358 in the first nine months of 2012.

	Nine Months Ended September 30,
	2013			2012
Selling, general and administrative expenses, GAAP	$	4,611		$	4,443
2012 Restructuring Program	(31		)	—
Business realignment and other cost-saving initiatives	—			(14		)
Selling, general and administrative expenses, non-GAAP	$	4,580		$	4,429

	Nine Months Ended September 30,
	2013		2012		Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP	35.3	%	34.7	%	60
2012 Restructuring Program	(0.2	)%	—
Business realignment and other cost-saving initiatives	—		(0.1	)%
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP	35.1	%	34.6	%	50

Other (income) expense, net

Other (income) expense, net was $359 in the first nine months of 2013 as compared to $37 in the first nine months of 2012.

Other (income) expense in the first nine months of 2013 included charges of $141 associated with the 2012 Restructuring Program, a one-time $172 charge for the impact of the devaluation in Venezuela, a charge of $18 for a competition law matter in France related to the home care and personal care sectors and costs of $3 related to the sale of land in Mexico. Other (income) expense in the first nine months of 2012 included costs of $2 associated with various business realignment and other cost-saving initiatives. Excluding the items described above in both periods, Other (income) expense, net decreased to $25 in the first nine months of 2013 from $35 in the first nine months of 2012.

	Nine Months Ended September 30,
	2013			2012
Other (income) expense, net, GAAP	$	359		$	37
2012 Restructuring Program	(141		)	—
Venezuela devaluation charge	(172		)	—
Charge for a French competition law matter	(18		)	—
Costs related to the sale of land in Mexico	(3		)	—
Business realignment and other cost-saving initiatives	—			(2		)
Other (income) expense, net, non-GAAP	$	25		$	35

35

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Operating Profit

Operating profit decreased 10% to $2,664 in the first nine months of 2013 from $2,947 in the first nine months of 2012. Operating profit in the first nine months of 2013 included charges of $198 associated with the 2012 Restructuring Program, a one-time $172 charge for the impact of the devaluation in Venezuela, a charge of $18 for a competition law matter in France related to the home care and personal care sectors and costs of $14 related to the sale of land in Mexico. Operating profit in the first nine months of 2012 included costs of $20 related to the sale of land in Mexico and costs of $21 associated with various business realignment and other cost-saving initiatives. Excluding the items described above in both periods, Operating profit for the first nine months of 2013 increased 3% to $3,066 from $2,988 in the first nine months of 2012, primarily due to sales growth and higher Gross profit margin.

Operating profit margin was 20.4% in the first nine months of 2013, a decrease of 260 bps compared to the first nine months of 2012. Excluding the impact of the items described above in both periods, Operating profit margin was 23.5%, an increase of 20 bps compared to the first nine months of 2012. This increase was mainly due to an increase in Gross profit margin (50 bps) and a decrease in Other (income) expense, net, partially offset by an increase in advertising investment (50 bps), both as a percentage of Net sales.

	Nine Months Ended September 30,
	2013		2012		% Change
Operating profit, GAAP	$	2,664	$	2,947	(10	)%
2012 Restructuring Program	198		—
Venezuela devaluation charge	172		—
Charge for a French competition law matter	18		—
Costs related to the sale of land in Mexico	14		20
Business realignment and other cost-saving initiatives	—		21
Operating profit, non-GAAP	$	3,066	$	2,988	3	%

	Nine Months Ended September 30,
	2013		2012		Basis Point Change
Operating profit margin, GAAP	20.4	%	23.0	%	(260	)
2012 Restructuring Program	1.5	%	—
Venezuela devaluation charge	1.3	%	—
Charge for a French competition law matter	0.2	%	—
Costs related to the sale of land in Mexico	0.1	%	0.1	%
Business realignment and other cost-saving initiatives	—		0.2	%
Operating profit margin, non-GAAP	23.5	%	23.3	%	20

Interest expense, net

Interest expense, net decreased to ($8) for the nine months ended September 30, 2013 from $20 in the comparable period of 2012, primarily due to an increase in interest income on investments held outside the U.S.

Income taxes

The effective tax rate was 31.2% for the third quarter of 2013 and 32.3% for the first nine months of 2013. The effective tax rate was 31.9% for the third quarter of 2012 and 31.8% for the first nine months of 2012. The quarterly and year-to-date provision for income taxes is determined based on the Company's estimated full year effective tax rate adjusted by the amount

36

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

of tax attributable to infrequent and unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company's current estimate of its full year effective income tax rate before discrete period items is 31.7%, compared to its previous estimate of 32.0% and 31.8% in the prior year. As a result of this change in estimate, the Company's effective tax rate for the third quarter of 2013, excluding charges associated with the 2012 Restructuring Program was 31.1%.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Effective tax rate, GAAP	31.2	%	31.9	%	32.3	%	31.8	%
2012 Restructuring Program	(0.1	)%	—		(0.6	)%	—
Charge for a French competition law matter	—		—		(0.2	)%	—
Venezuela devaluation charge	—		—		0.2	%	—
Costs related to the sale of land in Mexico	—		(0.1	)%	—		—
Effective tax rate, non-GAAP	31.1	%	31.8	%	31.7	%	31.8	%

Net income attributable to Colgate-Palmolive Company and Earnings per share

Net income attributable to Colgate-Palmolive Company in the first nine months of 2013 decreased to $1,677 from $1,874 in the comparable 2012 period, and earnings per common share on a diluted basis decreased to $1.78 per share from $1.95 per share in the comparable 2012 period. Net income attributable to Colgate-Palmolive Company in the first nine months of 2013 included charges of $153 associated with the 2012 Restructuring Program, a one-time $111 charge for the impact of the devaluation in Venezuela, a charge of $18 for a competition law matter in France related to the home care and personal care sectors and costs of $9 related to the sale of land in Mexico. Net income attributable to Colgate-Palmolive Company in the first nine months of 2012 included costs of $15 related to the sale of land in Mexico and costs of $14 associated with various business realignment and other cost-saving initiatives. Excluding these items, Net income attributable to Colgate-Palmolive Company increased 3% to $1,968 in the first nine months of 2013 from $1,903 in the first nine months of 2012 and earnings per common share on a diluted basis increased 6% to $2.09 in the first nine months of 2013 from $1.98 in the first nine months of 2012.

	Nine Months Ended September 30,
	2013		2012		% Change
Net income attributable to Colgate-Palmolive Company, GAAP	$	1,677	$	1,874	(11	)%
2012 Restructuring Program	153		—
Venezuela devaluation charge	111		—
Charge for a French competition law matter	18		—
Costs related to the sale of land in Mexico	9		15
Business realignment and other cost-saving initiatives	—		14
Net income attributable to Colgate-Palmolive Company, non-GAAP	$	1,968	$	1,903	3	%

37

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

	Nine Months Ended September 30,
	2013		2012		% Change
Earnings per common share, diluted, GAAP	$	1.78	$	1.95	(9	)%
2012 Restructuring Program	0.16		—
Venezuela devaluation charge	0.12		—
Charge for a French competition law matter	0.02		—
Costs related to the sale of land in Mexico	0.01		0.02
Business realignment and other cost-saving initiatives	—		0.01
Earnings per common share, diluted, non-GAAP	$	2.09	$	1.98	6	%

38

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Restructuring and Related Implementation Charges

2012 Restructuring Program

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program (the 2012 Restructuring Program) for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

The 2012 Restructuring Program is expected to produce significant benefits in the Company's long-term business performance. The major objectives of the program include:

▪ Becoming even stronger on the ground through the continued evolution and expansion of proven global and regional commercial capabilities, which have already been successfully implemented in a number of the Company's operations around the world.

▪ Simplifying and standardizing how work gets done by increasing technology-enabled collaboration and taking advantage of global data and analytic capabilities, leading to smarter and faster decisions.

▪ Reducing structural costs to continue to increase the Company's gross and operating profit.

▪ Building on Colgate's current position of strength to enhance its leading market share positions worldwide and ensure sustained sales and earnings growth.

Implementation of the 2012 Restructuring Program is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax), which are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (15%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (15%). Due to the acceleration of the implementation of certain program initiatives, the anticipated pretax charges for 2013 increased to approximately $365 to $390 ($290 to $305 aftertax) from approximately $260 to $310 ($185 to $220 aftertax) with no change to the amount of expected total program charges. Over the course of the 2012 Restructuring Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that by the end of 2016, the 2012 Restructuring Program will reduce the Company's global employee workforce by approximately 6% from the 2012 level of approximately 38,000.

Savings, substantially all of which are expected to increase future cash flows, are projected to be in the range of $365 to $435 pretax ($275 to $325 aftertax) annually by the fourth year of the program. Due to the acceleration of the implementation of certain program initiatives, savings for 2013 increased to approximately $45 to $55 ($40 to $45 aftertax) from approximately $40 to $50 ($30 to $40 aftertax) effective in the latter half of the year.

Initiatives under the program are focused on the following three areas:

▪ Expanding Commercial Hubs - Building on the success of this structure already implemented in several divisions, continuing to cluster single-country subsidiaries into more efficient regional hubs, in order to drive smarter and faster decision making, strengthen capabilities available on the ground and improve cost structure.

▪ Extending Shared Business Services and Streamlining Global Functions - Implementing the Company's shared service organizational model, already successful in Europe, in all regions of the world. Initially focused on finance and accounting, these shared services will be expanded to additional functional areas to streamline global functions.

39

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

▪ Optimizing Global Supply Chain and Facilities - Continuing to optimize manufacturing efficiencies, global warehouse networks and office locations for greater efficiency, lower cost and speed to bring innovation to market.

For the three and nine months ended September 30, 2013, restructuring and implementation-related charges are reflected in the income statement as follows:

	Three Months Ended		Nine Months Ended
	September 30, 2013		September 30, 2013
Cost of sales	$	8	$	26
Selling, general and administrative expenses	9		31
Other (income) expense, net	13		141
Total 2012 Restructuring Program charges, pretax	$	30	$	198
Total 2012 Restructuring Program charges, aftertax	$	22	$	153

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges for the 2012 Restructuring Program for the three months endedSeptember 30, 2013 relate to initiatives undertaken in North America (13%), Europe/South Pacific (22%), Latin America (6%), Hill’s Pet Nutrition (29%) and Corporate (30%). Total charges for the 2012 Restructuring Program for the nine months endedSeptember 30, 2013 relate to initiatives undertaken in North America (20%), Europe/South Pacific (35%), Latin America (6%), Africa/Eurasia (4%), Hill's Pet Nutrition (8%) and Corporate (27%). Total program-to-date accumulated charges for the 2012 Restructuring Program relate to initiatives undertaken in North America (14%), Europe/South Pacific (42%), Latin America (4%), Africa/Eurasia (3%), Hill's Pet Nutrition (6%) and Corporate (31%).

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $287 ($223 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of September 30, 2013
Employee-Related Costs	$	169
Incremental Depreciation	20
Asset Impairments	1
Other	97
Total	$	287

The majority of costs incurred since inception relate to the following projects: the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company's research and development capabilities and oral care supply chain, both in Europe; other exit costs related to office consolidation; and the restructuring of certain commercial operations in advance of implementing an overall hubbing strategy.

40

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

The following tables summarize the activity for the restructuring and implementation-related charges discussed above and the related accrual:

	Three Months Ended September 30, 2013
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at June 30, 2013	$	141		$	—		$	—	$	31		$	172
Charges	5			5			—		20			30
Cash payments	(40		)	—			—		(11		)	(51		)
Charges against assets	—			(5		)	—		—			(5		)
Foreign exchange	—			—			—		—			—
Balance at September 30, 2013	$	106		$	—		$	—	$	40		$	146

	Nine Months Ended September 30, 2013
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2012	$	84		$	—		$	—		$	5		$	89
Charges	91			20			1			86			198
Cash payments	(52		)	—			—			(51		)	(103		)
Charges against assets	(17		)	(20		)	(1		)	—			(38		)
Foreign exchange	—			—			—			—			—
Balance at September 30, 2013	$	106		$	—		$	—		$	40		$	146

Employee-related costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-related costs also include pension and other retiree benefit enhancements amounting to $17 for the nine months ended September 30, 2013, which are reflected as Charges against assets within Employee-related costs in the preceding tables, as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities.

Incremental depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Asset impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of implementation-related charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three and nine months ended September 30, 2013 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $11 and $35, respectively, and contract termination costs of $8 and $27, respectively, directly related to the 2012 Restructuring Program. These charges were expensed as incurred. These charges, for the nine months endedSeptember 30, 2013, also included a charge for other exit costs related to office space consolidation of $24.

41

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q discusses organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP). Management believes this measure provides investors with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange, as well as the impact of acquisitions and divestments. A reconciliation of organic sales growth to Net sales growth for the three-month and nine-month periods ended September 30, 2013 is provided below.

Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, effective tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Quarterly Report on Form 10-Q both on a GAAP basis and, as applicable, excluding the impacts of charges related to the 2012 Restructuring Program, the one-time charge resulting from the Venezuela devaluation, a charge for the competition law matter in France related to the home care and personal care sectors, costs related to the sale of land in Mexico and costs associated with various business realignment and other cost-saving initiatives (non-GAAP). Management believes these non-GAAP financial measures provide investors with useful supplemental information regarding the performance of the Company’s on-going operations. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the three-month and nine-month periods ended September 30, 2013 and 2012 is presented within the applicable section of Results of Operations.

The Company uses the above non-GAAP financial measures internally in its budgeting process and as a factor in determining compensation. While the Company believes that these non-GAAP financial measures are useful in evaluating the Company’s business, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

The following table provides a quantitative reconciliation of organic sales growth to Net sales growth for the three months endedSeptember 30, 2013.

Three months ended September 30, 2013	Organic Sales Growth (Non-GAAP)	Foreign Exchange Impact	Acquisitions and Divestments Impact	Net Sales Growth (GAAP)
Oral, Personal and Home Care
North America	1.5%	(0.5)%	0.0%	1.0%
Latin America	9.5%	(11.0)%	(0.5)%	(2.0)%
Europe/South Pacific	1.0%	1.0%	(0.5)%	1.5%
Asia	10.5%	(3.0)%	0.0%	7.5%
Africa/Eurasia	8.5%	(6.5)%	0.0%	2.0%
Total Oral, Personal and Home Care	6.0%	(4.5)%	0.0%	1.5%
Pet Nutrition	6.0%	(3.0)%	0.0%	3.0%
Total Company	6.0%	(4.5)%	0.0%	1.5%

42

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

The following table provides a quantitative reconciliation of organic sales growth to Net sales growth for the nine months endedSeptember 30, 2013.

Nine months ended September 30, 2013	Organic Sales Growth (Non-GAAP)	Foreign Exchange Impact	Acquisitions and Divestments Impact	Net Sales Growth (GAAP)
Oral, Personal and Home Care
North America	4.0%	(0.5)%	0.0%	3.5%
Latin America	8.5%	(9.0)%	(0.5)%	(1.0)%
Europe/South Pacific	0.0%	0.0%	(0.5)%	(0.5)%
Asia	11.5%	(1.0)%	0.0%	10.5%
Africa/Eurasia	7.0%	(5.5)%	0.0%	1.5%
Total Oral, Personal and Home Care	6.0%	(3.5)%	(0.5)%	2.0%
Pet Nutrition	4.0%	(2.5)%	0.0%	1.5%
Total Company	5.5%	(3.5)%	0.0%	2.0%

43

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Liquidity and Capital Resources

The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures, costs associated with the 2012 Restructuring Program and stock repurchases). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.

Net cash provided by operations increased 11% to $2,365 in the first nine months of 2013, compared with $2,133 in the comparable period of 2012. The increase in net cash provided by operations in the first nine months of 2013 was driven by strong operating earnings and management of working capital.

The Company defines working capital as the difference between current assets (excluding cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt). Overall, the Company’s working capital decreased to (0.9%) of Net sales in the first nine months of 2013 as compared with 2.2% in the first nine months of 2012, primarily due to an improvement in accounts receivable days sales outstanding, an increase in accounts payable and accrued liabilities, in part related to the 2012 Restructuring Program, and the timing of dividend payments.

Approximately 75% of total program charges related to the 2012 Restructuring Program, currently estimated between $1,100 and $1,250 ($775 and $875 aftertax), are expected to result in cash expenditures. Savings are currently projected to be in the range of $365 to $435 ($275 to $325 aftertax) annually by the fourth year of the program, substantially all of which are expected to increase future cash flows. The anticipated charges for 2013 are expected to amount to approximately $365 to $390 ($290 to $305 aftertax) and savings in 2013 should approximate $45 to $55 ($40 to $45 aftertax). It is anticipated that cash requirements for the 2012 Restructuring Program will be funded from operating cash flows.

Investing activities used $628 in the first nine months of 2013, compared with $624 in the comparable period of 2012. Purchases of marketable securities and investments decreased in the first nine months of 2013 to $408 from $501 in the comparable period of 2012 primarily due to a decrease in the Company’s investments through its subsidiary in Venezuela in local currency denominated fixed interest rate bonds issued by the Venezuelan government. In the third quarter of 2011, the Company’s Mexican subsidiary entered into an agreement to sell the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2012, the Company received the second installment of $36. Capital spending increased in the first nine months of 2013 to $419 from $317 in the comparable period of 2012. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns. Overall capital expenditures for 2013 are expected to be at an annual rate of approximately 4.5% of Net sales, reflecting a higher level of investment primarily driven by the 2012 Restructuring Program.

Financing activities used $1,810 of cash during the first nine months of 2013 compared with $1,458 in the comparable period of 2012, reflecting higher principal payments on debt, partially offset by higher proceeds from issuance of debt and lower purchases of treasury shares in the first nine months of 2013 compared to the first nine months of 2012. 

Long-term debt, including the current portion, increased to $5,265 as of September 30, 2013 as compared to $5,176 as of December 31, 2012 and total debt increased to $5,284 as of September 30, 2013 as compared to $5,230 as of December 31, 2012. During the second quarter of 2013, the Company issued $400 of five-year notes at a fixed rate of 0.90% and $400 of ten-year notes at a fixed rate of 2.10% under the Company's shelf registration statement. During the second quarter of 2012, the Company issued $500 of ten-year notes at a fixed rate of 2.30% under the Company’s shelf registration statement. During the third quarter of 2012, the Company issued $500 of ten-year notes at a fixed rate of 1.95% under the Company’s shelf registration statement. Proceeds from the debt issuances in the second quarter of 2012 and the third quarter of 2012 were used to reduce commercial paper borrowings, which were used by the Company for general corporate purposes. Proceeds from the debt issuances in the second quarter of 2013 were used to reduce commercial paper borrowings, which were used by the Company for general corporate purposes, and to repay and retire $250 of notes due in 2013.

As of September 30, 2013, the Company had no commercial paper outstanding. Commercial paper outstanding was $462 as of September 30, 2012. The average daily balances outstanding for commercial paper in the first nine months of 2013 and 2012 were $1,761 and $1,598, respectively. The maximum daily balances outstanding for commercial paper in the first nine months

44

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

of 2013 and 2012 were $2,123 and $2,042, respectively. The Company regularly classifies commercial paper and certain current maturities of notes payable as long-term debt as it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its line of credit that expires in 2017.

Certain of the facilities with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

In the first quarter of 2013, the Company increased the annualized common stock dividend by 10% to $1.36 per share, effective in the second quarter of 2013. On September 8, 2011, the Company’s Board of Directors (the Board) approved a share repurchase program that authorized the repurchase of up to 50 million shares of the Company’s common stock (the 2011 Program). On March 7, 2013, the Board approved a two-for-one stock split of the Company's common stock to be effected through a 100% stock dividend. The record date for the two-for-one split was the close of business on April 23, 2013 and the share distribution occurred on May 15, 2013. The Board authorized that the number of shares remaining under the 2011 Program as of May 15, 2013 be increased by 100% as a result of the two-for-one split.

Cash and cash equivalents decreased $163 during the first nine months of 2013 to $721 at September 30, 2013, compared to $884 at December 31, 2012, most of which ($659 and $861, respectively) were held by the Company’s foreign subsidiaries. These amounts include $57 and $170, respectively, which are subject to currency exchange controls in Venezuela, limiting the total amount of Cash and cash equivalents held by the Company’s foreign subsidiaries that can be repatriated at any particular point in time. The Company regularly assesses its cash needs and the available sources to fund these needs and, as part of this assessment, the Company determines the amount of foreign earnings it intends to repatriate to help fund its domestic cash needs and provides applicable U.S. income and foreign withholding taxes on such earnings.

As of December 31, 2012, the Company had approximately $4,300 of undistributed earnings of foreign subsidiaries for which no U.S. income or foreign withholding taxes have been provided as the Company does not currently anticipate a need to repatriate these earnings. These earnings have been and currently are considered to be indefinitely reinvested and, therefore, are not subject to such taxes. Should these earnings be repatriated in the future, they would be subject to applicable U.S. income and foreign withholding taxes. Determining the tax liability that would arise if these earnings were repatriated is not practicable.

For additional information regarding liquidity and capital resources, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Quarterly Report on Form 10-Q are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data.

Market share data is subject to limitations on the availability of up-to-date information. We believe that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the SEC in its rules, regulations and releases. Such statements may relate, for example, to sales or volume growth, organic sales growth, profit or profit margin growth, earnings growth, financial goals, the impact of currency devaluations and exchange controls, price controls and labor unrest, including in Venezuela, cost-reduction plans including the 2012 Restructuring Program, tax rates, new product introductions or commercial investment levels, among other

45

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves, including the uncertain economic environment in different countries and its effect on consumer spending habits, increased competition and evolving competitive practices, currency rate fluctuations, exchange controls, price controls, labor relations, changes in foreign or domestic laws or regulations or their interpretation, political and fiscal developments, the availability and cost of raw and packaging materials, the ability to maintain or increase selling prices as needed, the ability to implement the 2012 Restructuring Program as planned or differences between the actual and the estimated costs or savings under such program, changes in the policies of retail trade customers and the ability to continue lowering costs. For information about these and other factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2012, including the information set forth under the captions “Item 1A. Risk Factors” and “Cautionary Statement on Forward-Looking Statements.”

Quantitative and Qualitative Disclosures about Market Risk

There is no material change in the information reported under Part II, Item 7, “Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure” contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012.

46

COLGATE-PALMOLIVE COMPANY

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of the Company’s Chairman of the Board, President and Chief Executive Officer and its Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of September 30, 2013 (the Evaluation). Based upon the Evaluation, the Company’s Chairman of the Board, President and Chief Executive Officer and its Chief Financial Officer concluded that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) are effective.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

47

COLGATE-PALMOLIVE COMPANY

PART II.OTHER INFORMATION

Item 1.Legal Proceedings

For information regarding legal matters, please refer to Item 3 in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012, Note 12 to the Consolidated Financial Statements included therein and Note 12 to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q.

Item 1A.Risk Factors

For information regarding risk factors, please refer to Part 1, Item 1A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.

48

COLGATE-PALMOLIVE COMPANY

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

The share repurchase program approved by the Board on September 8, 2011 (the 2011 Program) authorized the repurchase of up to 50 million shares of the Company’s common stock. On March 7, 2013, the Company's Board of Directors (the Board) approved a two-for-one stock split of the Company's common stock to be effected through a 100% stock dividend. The record date for the two-for-one split was the close of business on April 23, 2013 and the share distribution occurred on May 15, 2013. The Board authorized that the number of shares remaining under the 2011 Program as of May 15, 2013 be increased by 100% as a result of the two-for-one split. The Board also has authorized share repurchases on an on-going basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares will be repurchased from time to time in open market transactions or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the share repurchase activity for the three months in the quarter ended September 30, 2013:

Month	Total Number of Shares Purchased(1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
July 1 through 31, 2013	1,152,986	$	58.85	900,976	36,994,854
August 1 through 31, 2013	2,236,476	$	59.27	2,230,781	34,764,073
September 1 through 30, 2013	2,247,535	$	59.23	2,149,500	32,614,573
Total	5,636,997	$	59.17	5,281,257

⁽¹⁾  Includes share repurchases under the 2011 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

⁽²⁾  The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 355,740 shares, all of which relate to shares deemed surrendered to the Company to satisfy certain employee elections under its compensation and benefit programs.

Item 3.Defaults Upon Senior Securities

None.

Item 4.Mine Safety Disclosures

Not Applicable.

Item 5.Other Information

None.

49

COLGATE-PALMOLIVE COMPANY

Item 6.Exhibits

Exhibit No.	Description
10-A	Colgate-Palmolive Company Executive Severance Plan, as amended and restated through September 12, 2013. (Registrant hereby incorporates by reference Exhibit 10-A to its Current Report on Form 8-K filed on September 16, 2013, File No. 1-644.)
12	Computation of Ratio of Earnings to Fixed Charges.
31-A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
31-B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
32	Certificate of the Chairman of the Board, President and Chief Executive Officer and the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350.
101	The following materials from Colgate-Palmolive Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2013, formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income; (ii) the Condensed Consolidated Statements of Comprehensive Income; (iii) the Condensed Consolidated Balance Sheets; (iv) the Condensed Consolidated Statements of Cash Flows; and (v) Notes to Condensed Consolidated Financial Statements.

50

COLGATE-PALMOLIVE COMPANY

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	COLGATE-PALMOLIVE COMPANY
	(Registrant)
	Principal Executive Officer:
October 24, 2013	/s/ Ian Cook
	Ian Cook
	Chairman of the Board, President and Chief Executive Officer
	Principal Financial Officer:
October 24, 2013	/s/ Dennis J. Hickey
	Dennis J. Hickey
	Chief Financial Officer
	Principal Accounting Officer:
October 24, 2013	/s/ Victoria L. Dolan
	Victoria L. Dolan
	Vice President and Corporate Controller

51

EX-12

EXHIBIT 12

COLGATE-PALMOLIVE COMPANY

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Dollars in Millions Except as Indicated)

(Unaudited)

	Nine Months Ended September 30, 2013
Earnings:
Income before income taxes	$	2,672
Add:
Fixed charges	146
Less:
Income from equity investees	(4		)
Capitalized interest	(3		)
Income as adjusted	$	2,811
Fixed Charges:
Interest on indebtedness and amortization of debt expense and discount or premium	$	86
Portion of rents representative of interest factor	57
Capitalized interest	3
Total Fixed Charges	$	146
Ratio of earnings to fixed charges	19.3

EX-31.A

EXHIBIT 31-A

I, Ian Cook, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 24, 2013

/s/ Ian Cook

Ian Cook

Chairman of the Board, President and

Chief Executive Officer

EX-31.B

EXHIBIT 31-B

I, Dennis J. Hickey, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 24, 2013

/s/ Dennis J. Hickey

Dennis J. Hickey

Chief Financial Officer

EX-32

EXHIBIT 32

The undersigned Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer of Colgate-Palmolive Company each certify, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, that:

(1) the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2013 (the “Periodic Report”) which this statement accompanies fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Colgate-Palmolive Company.

Date: October 24, 2013

/s/ Ian Cook

Ian Cook

Chairman of the Board, President and

Chief Executive Officer

/s/ Dennis J. Hickey

Dennis J. Hickey

Chief Financial Officer

XML

Retirement Plans and Other Retiree Benefits

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Retirement Plans and Other Retiree Benefits

Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three-month and nine-month periods ended September 30, 2013 and 2012 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended September 30,
	2013			2012			2013			2012			2013			2012
Service cost	$	6		$	4		$	6		$	6		$	3		$	2
Interest cost	22			24			8			9			8			9
ESOP offset	—			—			—			—			—			—
Expected return on plan assets	(29		)	(28		)	(7		)	(7		)	(1		)	(1		)
Amortization of transition and prior service costs (credits)	1			2			1			1			—			—
Amortization of actuarial loss	17			17			3			2			5			5
Net periodic benefit cost	$	17		$	19		$	11		$	11		$	15		$	15

	Pension Benefits												Other Retiree Benefits
	United States						International
	Nine Months Ended September 30,
	2013			2012			2013			2012			2013			2012
Service cost	$	20		$	18		$	16		$	17		$	10		$	8
Interest cost	68			73			22			26			28			30
ESOP offset	—			—			—			—			(1		)	(1		)
Expected return on plan assets	(88		)	(84		)	(19		)	(19		)	(2		)	(2		)
Amortization of transition and prior service costs (credits)	6			7			1			1			—			2
Amortization of actuarial loss	49			46			10			7			16			13
Net periodic benefit cost	$	55		$	60		$	30		$	32		$	51		$	50

For each of the nine months endedSeptember 30, 2013 and 2012, the Company made voluntary contributions of $101 to its U.S. postretirement plans.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Current Assets
Cash and cash equivalents	$ 721	$ 884
Receivables (net of allowances of $65 and $61, respectively)	1,737	1,668
Inventories	1,441	1,365
Other current assets	701	639
Total current assets	4,600	4,556
Property, plant and equipment:
Cost	8,051	7,821
Less: Accumulated depreciation	(4,193)	(3,979)
Property, plant and equipment, net	3,858	3,842
Goodwill, net	2,471	2,500
Other intangible assets, net	1,487	1,499
Deferred income taxes	91	92
Other assets	932	905
Total assets	13,439	13,394
Current Liabilities
Notes and loans payable	19	54
Current portion of long-term debt	588	250
Accounts payable	1,234	1,290
Accrued income taxes	283	254
Other accruals	2,367	1,888
Total current liabilities	4,491	3,736
Long-term debt	4,677	4,926
Deferred income taxes	312	293
Other liabilities	1,952	2,049
Shareholders' Equity
Common stock	1,466	1,466
Additional paid-in capital	912	818
Retained earnings	17,393	16,953
Accumulated other comprehensive income (loss)	(2,716)	(2,621)
Unearned compensation	(35)	(41)
Treasury stock, at cost	(15,236)	(14,386)
Total Colgate-Palmolive Company shareholders' equity	1,784	2,189
Noncontrolling interests	223	201
Total shareholders' equity	2,007	2,390
Total liabilities and shareholders' equity	$ 13,439	$ 13,394

XML

Acquisitions and Divestitures

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Acquisitions and Divestitures

Acquisitions and Divestitures

Sale of Land in Mexico

On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The Company is re-investing these payments to relocate its soap production to a new state-of-the-art facility to be constructed at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. As a result, the Company expects to make capital improvements and incur costs to exit the site through 2014. These exit costs will primarily be related to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. During the three months endedSeptember 30, 2013 and 2012, the Company incurred $3 and $7 of pretax costs ($2 and $5 of aftertax costs), respectively, related to the sale. During the nine months endedSeptember 30, 2013 and 2012, the Company incurred $14 and $20 of pretax costs ($9 and $15 of aftertax costs), respectively, related to the sale.

XML

Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Shareholders' Equity

Changes in the components of Shareholders’ Equity for the nine months endedSeptember 30, 2013 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2012	$	1,466	$	818		$	(41	)	$	(14,386	)	$	16,953		$	(2,621	)	$	201
Net income												1,677						132
Other comprehensive income, net of tax															(95		)	(7		)
Dividends												(1,237		)				(108		)
Stock-based compensation expense			105
Shares issued for stock options			64						195
Shares issued for restricted stock awards			(72		)				72
Treasury stock acquired									(1,115		)
Other			(3		)	6			(2		)							5
Balance, September 30, 2013	$	1,466	$	912		$	(35	)	$	(15,236	)	$	17,393		$	(2,716	)	$	223

Accumulated other comprehensive income (loss) includes cumulative foreign currency translation losses of $1,767 and $1,609 at September 30, 2013 and December 31, 2012, respectively, and unrecognized pension and other retiree benefit costs of $997 and $1,053 at September 30, 2013 and December 31, 2012, respectively.

XML

Contingencies

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Contingencies

Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

As a matter of course, the Company is regularly audited by the IRS and other tax authorities around the world in countries where it conducts business. In this regard, all U.S. federal income tax returns through December 31, 2007 have been audited by the IRS and there are limited matters in administrative appeals for years 2002 through 2007, the settlement of which is not expected to have a material adverse effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S., state and local income tax examinations for the years prior to 2007. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years. Estimated incremental tax payments related to potential disallowances for subsequent periods are not expected to be material.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $250 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

In 2001, the Central Bank of Brazil sought to impose a substantial fine on the Company’s Brazilian subsidiary based on alleged foreign exchange violations in connection with the financing of the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (formerly American Home Products) (the Seller), as described in the Company’s Form 8-K dated January 10, 1995. The Company appealed the imposition of the fine to the Brazilian Monetary System Appeals Council (the Council) and, on January 30, 2007, the Council decided the appeal in the Company’s favor, dismissing the fine entirely. However, certain tax and civil proceedings related to the same acquisition of the Kolynos oral care business are still outstanding as described below.

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, are approximately $120. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process with the following results to date:

▪ In June 2005, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1996 through 1998. In March 2007, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1999 through 2001. The tax authorities appealed these decisions to the next administrative level.

▪ In August 2009, the First Taxpayers’ Council (the next and final administrative level of appeal) overruled the decisions of the First Board of Taxpayers, upholding the majority of the assessments, disallowing a portion of the assessments and remanding a portion of the assessments for further consideration by the First Board of Taxpayers.

The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers’ Council and further appeals are available within the Brazilian federal courts. The Company intends to challenge these assessments vigorously. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel and other advisors, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts.

In 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $75, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company is disputing the assessment within the internal revenue authority’s administrative appeals process. In October 2007, the Second Board of Taxpayers, which has jurisdiction over these matters, ruled in favor of the internal revenue authority. In January 2008, the Company appealed this decision, and in January 2012, a special appeals chamber of the Taxpayers’ Council denied the Company’s appeal. The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers' Council and further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the advice of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.

European Competition Matters

Since February 2006, the Company has learned that investigations relating to potential competition law violations involving the Company’s subsidiaries had been commenced by governmental authorities in a number of European countries and by the European Commission. The Company understands that substantially all of these investigations also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.

Fines have been imposed on the Company in the following matters, although, as noted below, the Company has appealed each of these fines:

▪ In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland. The Company is appealing the fine in the Swiss courts.

▪ In January 2010, Colgate’s Spanish subsidiary was fined $3 by the Spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing, which the Company contested. The fine was annulled by the Court of Appeal in July 2013. The Spanish competition law authority is appealing this judgment before the Supreme Court.

▪ In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.

▪ In December 2011, the French competition law authority found that four consumer goods companies had entered into agreements on pricing and promotion of heavy duty detergents for which Colgate’s French subsidiary was fined $46 in connection with a divested business. The Company is appealing the fine in the French courts.

▪ In March 2012, the French competition law authority found that three pet food producers, including the Company’s Hill’s France subsidiary, had violated the competition law, for which it imposed a fine of $7 on the Company’s Hill’s France subsidiary for alleged restrictions on exports from France, which the Company contested. In October 2013, the Company’s appeal was denied. The Company is evaluating whether to pursue further appeals.

Currently, formal claims of violations, or statements of objections, are pending against the Company as follows:

▪ The Belgian competition law authority has alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices on the Belgian market. The Company is in the process of responding to this statement of objections.

▪ In the second quarter of 2013, the French competition law authority issued a statement of objections alleging that the Company's French subsidiary and a number of its competitors exchanged sensitive information related to the French home care and personal care sectors. The Company has responded to this statement of objections.

An investigation is ongoing in Greece, but no formal claim of violations has been filed.

Since December 31, 2012, the following matter has been resolved:

▪ In March 2013, the German competition authority completed its investigation and no penalties were imposed against the Company or its German subsidiary.

The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The Company has undertaken a comprehensive review of its selling practices and related competition law compliance in Europe and elsewhere and, where the Company has identified a lack of compliance, it has undertaken remedial action. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate.

ERISA Matters

In October 2007, a putative class action claiming that certain aspects of the cash balance portion of the Colgate-Palmolive Company Employees’ Retirement Income Plan (the Plan) do not comply with the Employee Retirement Income Security Act was filed against the Plan and the Company in the United States District Court for the Southern District of New York. Specifically, Proesel, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al. alleges improper calculation of lump sum distributions, age discrimination and failure to satisfy minimum accrual requirements, thereby resulting in the underpayment of benefits to Plan participants.

Two other putative class actions filed earlier in 2007, Abelman, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al., in the United States District Court for the Southern District of Ohio, and Caufield v. Colgate-Palmolive Company Employees’ Retirement Income Plan, in the United States District Court for the Southern District of Indiana, both alleging improper calculation of lump sum distributions and, in the case of Abelman, claims for failure to satisfy minimum accrual requirements, were transferred to the Southern District of New York and consolidated with Proesel into one action, In re Colgate-Palmolive ERISA Litigation. The complaint in the consolidated action alleges improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements, but does not include a claim for age discrimination. The relief sought includes recalculation of benefits in unspecified amounts, pre- and post-judgment interest, injunctive relief and attorneys’ fees. In October 2013, the parties executed a settlement agreement under which the Plan would pay approximately $40 after application of certain offsets to resolve the litigation. The settlement agreement is subject to court approval. On October 9, 2013, a motion for preliminary approval of a class action settlement, class certification and appointment of class counsel was filed. The Company and the Plan intend to contest this action vigorously should the settlement not be approved and finalized.

XML

Other Comprehensive Income (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2013		Sep. 30, 2012		Sep. 30, 2013		Sep. 30, 2012
Other Comprehensive Income (Loss) [Abstract]
Cumulative translation adjustments, before-tax	$ 82		$ 79		$ (170)		$ (26)
Cumulative translation adjustment, net-of-tax	93		81		(158)		(27)
Pension and other benefits:
Net actuarial gains (losses) and prior service costs arising during the period, before-tax	1		13		4		(19)
Net actuarial gains (losses) and prior service costs arising during the period, net-of-tax	1		8		3		(14)
Amortization of net actuarial loss, transition & prior service costs, before-tax	27	[1]	27	[1]	82	[1]	76	[1]
Amortization of net actuarial loss, transition & prior service costs, net-of-tax	17	[1]	17	[1]	53	[1]	49	[1]
Retirement Plan and other retiree benefit adjustments, before-tax	28		40		86		57
Retirement Plan and other retiree benefit adjustments, net-of-tax	18		25		56		35
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities, before-tax	4		(8)		(124)		14
Unrealized gains (losses) on available-for-sale securities, net-of-tax	3		(5)		(79)		9
Reclassification of (gains) losses into net earnings on available-for-sale securities, before-tax	0		0		133	[2]	0	[2]
Reclassification of (gains) losses into net earnings on available-for-sale securities, net-of-tax	0		0		86	[2]	0	[2]
Gains (losses) on available-for-sale securities, before-tax	4		(8)		9		14
Gains (losses) on available-for-sale securities, net-of-tax	3		(5)		7		9
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges, before-tax	2		(1)		13		7
Unrealized gains (losses) on cash flow hedges, net-of-tax	0		0		8		5
Reclassification of (gains) losses into net earnings on cash flow hedges, before-tax	(8)	[3]	(3)	[3]	(13)	[3]	(4)	[3]
Reclassification of (gains) losses into net earnings on cash flow hedges, net-of-tax	(5)	[3]	(2)	[3]	(8)	[3]	(2)	[3]
Gains (losses) on cash flow hedges, before-tax	(6)		(4)		0		3
Gains (losses) on cash flow hedges, net-of-tax	(5)		(2)		0		3
Total other comprehensive income (loss), before-tax	108		107		(75)		48
Total other comprehensive income (loss), net-of-tax	$ 109		$ 99		$ (95)		$ 20

[1] These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details.

[2] Represents the one-time loss related to the remeasurement of the fixed interest rate bonds in Venezuela which was recorded in Other (income) expense, net. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

[3] These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

XML

Retirement Plans and Other Retiree Benefits (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Components Of Net Periodic Benefit Cost

Components of Net periodic benefit cost for the three-month and nine-month periods ended September 30, 2013 and 2012 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended September 30,
	2013			2012			2013			2012			2013			2012
Service cost	$	6		$	4		$	6		$	6		$	3		$	2
Interest cost	22			24			8			9			8			9
ESOP offset	—			—			—			—			—			—
Expected return on plan assets	(29		)	(28		)	(7		)	(7		)	(1		)	(1		)
Amortization of transition and prior service costs (credits)	1			2			1			1			—			—
Amortization of actuarial loss	17			17			3			2			5			5
Net periodic benefit cost	$	17		$	19		$	11		$	11		$	15		$	15

	Pension Benefits												Other Retiree Benefits
	United States						International
	Nine Months Ended September 30,
	2013			2012			2013			2012			2013			2012
Service cost	$	20		$	18		$	16		$	17		$	10		$	8
Interest cost	68			73			22			26			28			30
ESOP offset	—			—			—			—			(1		)	(1		)
Expected return on plan assets	(88		)	(84		)	(19		)	(19		)	(2		)	(2		)
Amortization of transition and prior service costs (credits)	6			7			1			1			—			2
Amortization of actuarial loss	49			46			10			7			16			13
Net periodic benefit cost	$	55		$	60		$	30		$	32		$	51		$	50

XML

Other Comprehensive Income (Tables)

9 Months Ended

Sep. 30, 2013

Other Comprehensive Income (Loss) [Abstract]

Schedule of Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedSeptember 30, 2013 and 2012 were as follows:

	2013						2012
	Pre-tax			Net of Tax			Pre-tax			Net of Tax
Cumulative translation adjustments	$	82		$	93		$	79		$	81
Pension and other benefits:
Net actuarial gains (losses) and prior service costs arising during the period	1			1			13			8
Amortization of net actuarial losses, transition and prior service costs (1)	27			17			27			17
Retirement Plan and other retiree benefit adjustments	28			18			40			25
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	4			3			(8		)	(5		)
Reclassification of (gains) losses into net earnings on available-for-sale securities	—			—			—			—
Gains (losses) on available-for-sale securities	4			3			(8		)	(5		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	2			—			(1		)	—
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(8		)	(5		)	(3		)	(2		)
Gains (losses) on cash flow hedges	(6		)	(5		)	(4		)	(2		)
Total Other comprehensive income (loss)	$	108		$	109		$	107		$	99

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the nine months endedSeptember 30, 2013 and 2012 were as follows:

	2013						2012
	Pre-tax			Net of Tax			Pre-tax			Net of Tax
Cumulative translation adjustments	$	(170	)	$	(158	)	$	(26	)	$	(27	)
Pension and other benefits:
Net actuarial gains (losses) and prior service costs arising during the period	4			3			(19		)	(14		)
Amortization of net actuarial losses, transition and prior service costs (1)	82			53			76			49
Retirement Plan and other retiree benefit adjustments	86			56			57			35
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	(124		)	(79		)	14			9
Reclassification of (gains) losses into net earnings on available-for-sale securities (2)	133			86			—			—
Gains (losses) on available-for-sale securities	9			7			14			9
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	13			8			7			5
Reclassification of (gains) losses into net earnings on cash flow hedges (3)	(13		)	(8		)	(4		)	(2		)
Gains (losses) on cash flow hedges	—			—			3			3
Total Other comprehensive income (loss)	$	(75	)	$	(95	)	$	48		$	20

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾Represents the one-time loss related to the remeasurement of the fixed interest rate bonds in Venezuela which was recorded in Other (income) expense, net. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

⁽³⁾These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

XML

Fair Value Measurements and Financial Instruments (Details 5) (Bonds Issued By Venezuelan Government [Member], USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2010
Bonds Issued By Venezuelan Government [Member]
Venezuelan Investments [Roll Forward]
Beginning balance	$ 642		$ 236
Unrealized gain (loss) on investment	(124)	14
Purchases and sales during the period	182	373
Ending balance	$ 700	$ 623	$ 236

XML

Inventories (Details) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Inventory, Net [Abstract]
Raw materials and supplies	$ 340	$ 362
Work-in-process	58	81
Finished goods	1,043	922
Total Inventories	$ 1,441	$ 1,365

XML

Contingencies (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Oct. 09, 2013
Loss Contingency [Abstract]
Minimum Number Of Countries And Territories Serving Consumers	200
Range of reasonably possible losses, minimum	$ 0
Range of reasonably possible losses, maximum	250
Brazilian internal revenue authority, matter 1	120
Brazilian internal revenue authority, matter 2	75
European competition matters - Swiss competition law authority	6
European competition matters - Spanish competition law authority	3
European competition matters - Italian competition law authority	3
European competition matters - French competition law authority	46
European competition matters - Hill's France Subsidiary	7
ERISA Matter		$ 40

XML

Restructuring and Related Implementation Charges (Details) (Two Thousand Twelve Restructuring Program [Member], USD $) In Millions, unless otherwise specified	3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended			3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013 One-time Termination Benefits [Member]	Sep. 30, 2013 One-time Termination Benefits [Member]	Sep. 30, 2013 Incremental Depreciation And Asset Impairment [Member]	Sep. 30, 2013 Charges Resulting Directly From Exit Activities [Member]	Sep. 30, 2013 Contract Termination [Member]	Sep. 30, 2013 Contract Termination [Member]	Sep. 30, 2013 Implementation Of New Strategies [Member]	Sep. 30, 2013 Third party Incremental Cost [Member]	Sep. 30, 2013 Third party Incremental Cost [Member]	Sep. 30, 2013 Land and Building [Member]	Sep. 30, 2013 Expected Completion Date 2016 Minimum [Member]	Sep. 30, 2013 Expected Completion Date 2016 Maximum [Member]	Sep. 30, 2013 Expected Completion Date December 2013 Minimum [Member]	Jun. 30, 2013 Expected Completion Date December 2013 Minimum [Member]	Sep. 30, 2013 Expected Completion Date December 2013 Maximum [Member]	Jun. 30, 2013 Expected Completion Date December 2013 Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 30	$ 198		$ 5	$ 91			$ 8	$ 27		$ 11	$ 35	$ 24
Duration Of Restructuring Program			4 years
Restructuring Program Expected Cost Before Tax														1,100	1,250	365	260	390	310
Restructuring Program Expected Cost After Tax														$ 775	$ 875	$ 290	$ 185	$ 305	$ 220
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing 2012 Restructuring Program				50.00%	50.00%	15.00%	20.00%			15.00%
Percent of Restructuring Charges Resulting In Cash Expenditure	75.00%	75.00%

XML

Fair Value Measurements and Financial Instruments (Details 2) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Debt Instrument, Fair Value Disclosure	$ 5,465	$ 5,484
Carrying Value [Member]
Debt Instrument [Line Items]
Long-term debt	$ 5,265	$ 5,176

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2013

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

	Three Months Ended
	September 30, 2013					September 30, 2012
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	656	928.1	$	0.71	$	654	949.8	$	0.69
Stock options and restricted stock			8.8					8.6
Diluted EPS	$	656	936.9	$	0.70	$	654	958.4	$	0.68

For the three months endedSeptember 30, 2013 and 2012, the average number of stock options and restricted stock awards that were anti-dilutive and not included in diluted earnings per share calculations were 1,956,750 and 1,214,526, respectively.

	Nine Months Ended
	September 30, 2013					September 30, 2012
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	1,677	932.5	$	1.80	$	1,874	954.8	$	1.96
Stock options and restricted stock			8.9					8.1
Diluted EPS	$	1,677	941.4	$	1.78	$	1,874	962.9	$	1.95

For the nine months endedSeptember 30, 2013 and 2012, the average number of stock options and restricted stock awards that were anti-dilutive and not included in diluted earnings per share calculations were 703,219 and 1,259,888, respectively.

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Operating Activities
Net income including noncontrolling interests	$ 1,809	$ 1,995
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	329	317
Restructuring and termination benefits, net of cash	82	(35)
Voluntary benefit plan contributions	(101)	(101)
Stock-based compensation expense	105	98
Venezuela devaluation charge	172	0
Deferred income taxes	35	71
Cash effects of changes in:
Receivables	(137)	(166)
Inventories	(107)	(48)
Accounts payable and other accruals	121	(27)
Other non-current assets and liabilities	57	29
Net cash provided by operations	2,365	2,133
Investing Activities
Capital expenditures	(419)	(317)
Sale of property and non-core product lines	0	38
Purchases of marketable securities and investments	(408)	(501)
Proceeds from sale of marketable securities and investments	195	120
Payments for acquisitions, net of cash acquired	0	(29)
Other	4	65
Net cash used in investing activities	(628)	(624)
Financing Activities
Principal payments on debt	(5,504)	(3,684)
Proceeds from issuance of debt	5,563	4,131
Dividends paid	(1,030)	(951)
Purchases of treasury shares	(1,115)	(1,344)
Proceeds from exercise of stock options and excess tax benefits	276	390
Net cash used in financing activities	(1,810)	(1,458)
Effect of exchange rate changes on Cash and cash equivalents	(90)	(20)
Net increase (decrease) in Cash and cash equivalents	(163)	31
Cash and cash equivalents at beginning of the period	884	878
Cash and cash equivalents at end of the period	721	909
Supplemental Cash Flow Information
Income taxes paid	$ 781	$ 949

XML

Use of Estimates

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Use of Estimates

Use of Estimates

Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

XML

Restructuring and Related Implementation Charges

9 Months Ended

Sep. 30, 2013

Restructuring and Related Activities [Abstract]

Restructuring and Related Implementation Charges

Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program (the 2012 Restructuring Program) for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

Implementation of the 2012 Restructuring Program is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax), which are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (15%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (15%). Due to the acceleration of the implementation of certain program initiatives, the anticipated pretax charges for 2013 increased to approximately $365 to $390 ($290 to $305 aftertax) from approximately $260 to $310 ($185 to $220 aftertax) with no change to the amount of expected total program charges. Over the course of the 2012 Restructuring Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis.

For the three and nine months ended September 30, 2013, restructuring and implementation-related charges are reflected in the income statement as follows:

	Three Months Ended		Nine Months Ended
	September 30, 2013		September 30, 2013
Cost of sales	$	8	$	26
Selling, general and administrative expenses	9		31
Other (income) expense, net	13		141
Total 2012 Restructuring Program charges, pretax	$	30	$	198
Total 2012 Restructuring Program charges, aftertax	$	22	$	153

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges for the 2012 Restructuring Program for the three months endedSeptember 30, 2013 relate to initiatives undertaken in North America (13%), Europe/South Pacific (22%), Latin America (6%), Hill’s Pet Nutrition (29%) and Corporate (30%). Total charges for the 2012 Restructuring Program for the nine months endedSeptember 30, 2013 relate to initiatives undertaken in North America (20%), Europe/South Pacific (35%), Latin America (6%), Africa/Eurasia (4%), Hill's Pet Nutrition (8%) and Corporate (27%). Total program-to-date accumulated charges for the 2012 Restructuring Program relate to initiatives undertaken in North America (14%), Europe/South Pacific (42%), Latin America (4%), Africa/Eurasia (3%), Hill's Pet Nutrition (6%) and Corporate (31%).

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $287 ($223 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of September 30, 2013
Employee-Related Costs	$	169
Incremental Depreciation	20
Asset Impairments	1
Other	97
Total	$	287

The majority of costs incurred since inception relate to the following projects: the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company's research and development capabilities and oral care supply chain, both in Europe; other exit costs related to office consolidation; and the restructuring of certain commercial operations in advance of implementing an overall hubbing strategy.

The following tables summarize the activity for the restructuring and implementation-related charges discussed above and the related accrual:

	Three Months Ended September 30, 2013
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at June 30, 2013	$	141		$	—		$	—	$	31		$	172
Charges	5			5			—		20			30
Cash payments	(40		)	—			—		(11		)	(51		)
Charges against assets	—			(5		)	—		—			(5		)
Foreign exchange	—			—			—		—			—
Balance at September 30, 2013	$	106		$	—		$	—	$	40		$	146

	Nine Months Ended September 30, 2013
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2012	$	84		$	—		$	—		$	5		$	89
Charges	91			20			1			86			198
Cash payments	(52		)	—			—			(51		)	(103		)
Charges against assets	(17		)	(20		)	(1		)	—			(38		)
Foreign exchange	—			—			—			—			—
Balance at September 30, 2013	$	106		$	—		$	—		$	40		$	146

Employee-related costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-related costs also include pension and other retiree benefit enhancements amounting to $17 for the nine months ended September 30, 2013, which are reflected as Charges against assets within Employee-related costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities.

Incremental depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Asset impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of implementation-related charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three and nine months ended September 30, 2013 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $11 and $35, respectively, and contract termination costs of $8 and $27, respectively, directly related to the 2012 Restructuring Program. These charges were expensed as incurred. These charges, for the nine months endedSeptember 30, 2013, also included a charge for other exit costs related to office space consolidation of $24.

XML

Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2013

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

New Accounting Pronouncements and Changes in Accounting Principles [Text Block]

Recent Accounting Pronouncements

In July 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-10 “Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes”. ASU No. 2013-10 permits the Fed Funds Effective Swap Rate to be used as a benchmark interest rate for hedge accounting purposes and eliminates the restriction on using different benchmark interest rates for similar hedges. The new guidance is effective immediately and can be applied prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. This new guidance is not expected to have a material impact on the Company’s financial position or results of operations.

In July 2013, the FASB issued ASU No. 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”. ASU No. 2013-11 requires an entity to net its liability for unrecognized tax benefits against the deferred tax assets for all same jurisdiction net operating losses or similar tax loss carryforwards, or tax credit carryforwards. A gross presentation will be required only if such carryforwards are not available as of reporting date to settle any additional income taxes resulting from disallowance of the uncertain tax position or the entity does not intend to use these carryforwards for this purpose. The new guidance is effective on a prospective basis for fiscal years beginning after December 15, 2013 and interim periods within those years. This new guidance is not expected to have a material impact on the Company’s financial position or results of operations.

XML

Segment Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended			9 Months Ended
	Sep. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Notes to Financial Statements [Abstract]
Percentage Of Consolidated Net sales Represented By Caricom and Puerto Rico Subsidiary				1.00%
Percentage Of North America's Net sales Represented By Caricom and Puerto Rico Subsidiary		4.00%
Percentage Of Latin America's Net sales Represented By Caricom and Puerto Rico Subsidiary				3.00%
Segment Reporting Information [Line Items]
Pretax costs related to sale of land	$ 3		$ 7	$ 14	$ 20
Pretax Venezuela devaluation charge				172	0
Charge for French Competition Law Matter				18
Costs before tax associated with various Business Realignment and other cost-saving initiatives			3		21
Total Net sales	4,398		4,332	13,059	12,799
Total Operating profit	1,016		1,027	2,664	2,947
Operating Segments [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	3,853		3,804	11,431	11,198
Total Operating profit	1,057		1,019	3,038	2,911
Operating Segments [Member] | Pet Nutrition [Member]
Segment Reporting Information [Line Items]
Total Net sales	545		528	1,628	1,601
Total Operating profit	138		147	410	440
Operating Segments [Member] | North America [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	774		766	2,300	2,217
Total Operating profit	244		213	686	580
Operating Segments [Member] | Latin America [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	1,251		1,276	3,747	3,777
Total Operating profit	358		377	1,022	1,100
Operating Segments [Member] | Europe/South Pacific [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	880		865	2,552	2,569
Total Operating profit	216		198	605	560
Operating Segments [Member] | Asia [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	627		583	1,900	1,717
Total Operating profit	174		164	533	474
Operating Segments [Member] | Africa/Eurasia [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	321		314	932	918
Total Operating profit	65		67	192	197
Corporate, Non-Segment [Member] | Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Total Operating profit	(179)		(139)	(784)	(404)
Two Thousand Twelve Restructuring Program [Member]
Segment Reporting Information [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 30			$ 198
Sales Revenue, Net [Member]
Segment Reporting Information [Line Items]
Percentage of Consolidated Net Sales represented by Sales outside US	80.00%			80.00%
Percentage of Consolidated Net Sales coming from Emerging Markets	50.00%			50.00%

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Net Sales and Operating Profit by Segment

Net sales and Operating profit by segment were as follows:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2013			2012			2013			2012
Net sales
Oral, Personal and Home Care
North America	$	774		$	766		$	2,300		$	2,217
Latin America	1,251			1,276			3,747			3,777
Europe/South Pacific	880			865			2,552			2,569
Asia	627			583			1,900			1,717
Africa/Eurasia	321			314			932			918
Total Oral, Personal and Home Care	3,853			3,804			11,431			11,198
Pet Nutrition	545			528			1,628			1,601
Total Net sales	$	4,398		$	4,332		$	13,059		$	12,799
Operating profit
Oral, Personal and Home Care
North America	$	244		$	213		$	686		$	580
Latin America	358			377			1,022			1,100
Europe/South Pacific	216			198			605			560
Asia	174			164			533			474
Africa/Eurasia	65			67			192			197
Total Oral, Personal and Home Care	1,057			1,019			3,038			2,911
Pet Nutrition	138			147			410			440
Corporate	(179		)	(139		)	(784		)	(404		)
Total Operating profit	$	1,016		$	1,027		$	2,664		$	2,947

XML

Restructuring and Related Implementation Charges (Details 1) (Two Thousand Twelve Restructuring Program [Member], USD $) In Millions, unless otherwise specified	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 30	$ 198
Restructuring And Related Cost, Incurred Cost, After Tax	22	153
Restructuring and Related Cost, Cost Incurred to Date			287
Restructuring And Related Cost, Incurred Cost to Date, After Tax			223
One-time Termination Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	5	91
Restructuring and Related Cost, Cost Incurred to Date			169
Incremental Depreciation [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	5	20
Restructuring and Related Cost, Cost Incurred to Date			20
Asset Impairment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	0	1
Restructuring and Related Cost, Cost Incurred to Date			1
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	20	86
Restructuring and Related Cost, Cost Incurred to Date			97
Pet Nutrition [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program	10.00%	10.00%	10.00%
Percent Of Total Restructuring Charges Related To Segment for the period	29.00%	8.00%
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate			6.00%
Corporate [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program	40.00%	40.00%	40.00%
Percent Of Total Restructuring Charges Related To Segment for the period	30.00%	27.00%
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate			31.00%
North America [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program	15.00%	15.00%	15.00%
Percent Of Total Restructuring Charges Related To Segment for the period	13.00%	20.00%
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate			14.00%
Latin America [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program	5.00%	5.00%	5.00%
Percent Of Total Restructuring Charges Related To Segment for the period	6.00%	6.00%
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate			4.00%
Europe/South Pacific [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program	20.00%	20.00%	20.00%
Percent Of Total Restructuring Charges Related To Segment for the period	22.00%	35.00%
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate			42.00%
Asia [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program	5.00%	5.00%	5.00%
Africa/Eurasia [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment for the duration of the program	5.00%	5.00%	5.00%
Percent Of Total Restructuring Charges Related To Segment for the period		4.00%
PercentOfRestructuringChargesReportableSegmentProgramChargesIncurredToDate			3.00%
Cost of Sales [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	8	26
Selling, General and Administrative Expenses [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	9	31
Other (Income) Expense, Net [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 13	$ 141

XML

Common Stock Split (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Apr. 23, 2013
Common Stock Split, Pro Forma Information [Line Items]
Stockholders' Equity Note, Stock Split, Conversion Ratio	2
Stockholders' Equity Note Percent of Dividend in Shares	100.00%
Common Stock, Par or Stated Value Per Share		$ 1.00
Common Stock [Member]
Common Stock Split, Pro Forma Information [Line Items]
Stock Issued During Period, Value, Stock Dividend	$ 733
Adjustments to Additional Paid in Capital, Stock Split	$ 733

XML

Fair Value Measurements and Financial Instruments (Details 4) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Sep. 30, 2013	Sep. 30, 2013 Bonds Issued By Venezuelan Government [Member]	Dec. 31, 2012 Bonds Issued By Venezuelan Government [Member]	Sep. 30, 2012 Bonds Issued By Venezuelan Government [Member]	Dec. 31, 2010 Bonds Issued By Venezuelan Government [Member]	Sep. 30, 2013 Other Current Assets [Member]	Dec. 31, 2012 Other Current Assets [Member]	Sep. 30, 2013 Other Current Assets [Member] Fair Value Inputs Level1	Sep. 30, 2013 Other Current Assets [Member] Bonds Issued By Venezuelan Government [Member]	Sep. 30, 2013 Other Assets [Member] Available for Sale Securities	Dec. 31, 2012 Other Assets [Member] Available for Sale Securities
Schedule of Available-for-sale Securities [Line Items]
Marketable Securities							$ 146	$ 116	$ 122	$ 24
Available-for-sale Securities			700	642	623	236					676	618
Fair Value of U.S. dollar-linked, devaluation-protected bonds		257
Fair Value of fixed interest rate bonds		443
One-time loss related to the remeasurement of fixed interest rate bonds in Venezuela	$ 133

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net income including noncontrolling interests	$ 699	$ 697	$ 1,809	$ 1,995
Other comprehensive income, net of tax:
Cumulative translation adjustments	90	89	(165)	(23)
Retirement Plan and other retiree benefit adjustments	18	25	56	35
Gains (losses) on available-for-sale securities	3	(5)	7	9
Unrealized gains (losses) on cash flow hedges	(5)	(2)	0	3
Total Other comprehensive (loss) income, net of tax	106	107	(102)	24
Total Comprehensive income including noncontrolling interests	805	804	1,707	2,019
Less: Net income attributable to noncontrolling interests	43	43	132	121
Less: Cumulative translation adjustments attributable to noncontrolling interests	(3)	8	(7)	4
Total Comprehensive Income attributable to noncontrolling interests	40	51	125	125
Total Comprehensive income attributable to Colgate-Palmolive Company	$ 765	$ 753	$ 1,582	$ 1,894

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2013

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

	Three Months Ended
	September 30, 2013					September 30, 2012
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	656	928.1	$	0.71	$	654	949.8	$	0.69
Stock options and restricted stock			8.8					8.6
Diluted EPS	$	656	936.9	$	0.70	$	654	958.4	$	0.68

For the three months endedSeptember 30, 2013 and 2012, the average number of stock options and restricted stock awards that were anti-dilutive and not included in diluted earnings per share calculations were 1,956,750 and 1,214,526, respectively.

	Nine Months Ended
	September 30, 2013					September 30, 2012
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	1,677	932.5	$	1.80	$	1,874	954.8	$	1.96
Stock options and restricted stock			8.9					8.1
Diluted EPS	$	1,677	941.4	$	1.78	$	1,874	962.9	$	1.95

For the nine months endedSeptember 30, 2013 and 2012, the average number of stock options and restricted stock awards that were anti-dilutive and not included in diluted earnings per share calculations were 703,219 and 1,259,888, respectively.

As a result of the two-for-one stock split effective May 15, 2013, see Note 9, Common Stock Split, all historical per share data and number of shares were retroactively adjusted. Basic and diluted earnings per share were computed independently for each quarter and the year-to-date period presented. As a result of the stock split, changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not necessarily equal the earnings per share for the year-to-date period.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 65	$ 61

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net sales	$ 4,398	$ 4,332	$ 13,059	$ 12,799
Cost of sales	1,813	1,803	5,425	5,372
Gross profit	2,585	2,529	7,634	7,427
Selling, general and administrative expenses	1,549	1,501	4,611	4,443
Other (income) expense, net	20	1	359	37
Operating profit	1,016	1,027	2,664	2,947
Interest (income) expense, net	0	4	(8)	20
Income before income taxes	1,016	1,023	2,672	2,927
Provision for income taxes	317	326	863	932
Net income including noncontrolling interests	699	697	1,809	1,995
Less: Net income attributable to noncontrolling interests	43	43	132	121
Net income attributable to Colgate-Palmolive Company	$ 656	$ 654	$ 1,677	$ 1,874
Earnings per common share, basic (in dollars per share)	$ 0.71	$ 0.69	$ 1.80	$ 1.96
Earnings per common share, diluted (in dollars per share)	$ 0.70	$ 0.68	$ 1.78	$ 1.95
Dividends declared per common share (in dollars per share)	$ 0.34	$ 0.31	$ 1.33	$ 0.91

XML

Fair Value Measurements and Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Schedule of derivative instruments

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at September 30, 2013 and December 31, 2012:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		9/30/13		12/31/12			9/30/13		12/31/12
Interest rate swap contracts	Other current assets	$	1	$	3	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	22		41		Other liabilities	—		—
Foreign currency contracts	Other current assets	9		7		Other accruals	10		10
Foreign currency contracts	Other assets	3		13		Other liabilities	1		—
Commodity contracts	Other current assets	—		1		Other accruals	—		—
Total designated		$	35	$	65		$	11	$	10
Derivatives not designated
Foreign currency contracts	Other current assets	$	—	$	—	Other accruals	$	1	$	1
Total not designated		$	—	$	—		$	1	$	1
Total derivative instruments		$	35	$	65		$	12	$	11
Other financial instruments
Marketable securities	Other current assets	$	146	$	116
Available-for-sale securities	Other assets	676		618
Total other financial instruments		$	822	$	734

Activity related to fair value hedges

Activity related to fair value hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013									2012
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at September 30,	$	1,568		$	1,088		$	2,656		$	944		$	1,338		$	2,282
Three months ended September 30:
Gain (loss) on derivative	(9		)	2			(7		)	(8		)	5			(3		)
Gain (loss) on hedged items	9			(2		)	7			8			(5		)	3
Nine months ended September 30:
Gain (loss) on derivative	3			(18		)	(15		)	2			12			14
Gain (loss) on hedged items	(3		)	18			15			(2		)	(12		)	(14		)

Activity related to cash flow hedges

Activity related to cash flow hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013						2012
	Foreign Currency Contracts		Commodity Contracts		Total		Foreign Currency Contracts			Commodity Contracts		Total
Notional Value at September 30,	$	441	$	15	$	456	$	347		$	26	$	373
Three months ended September 30:
Gain (loss) recognized in OCI	2		—		2		(7		)	6		(1		)
Gain (loss) reclassified into Cost of sales	8		—		8		(1		)	4		3
Nine months ended September 30:
Gain (loss) recognized in OCI	13		—		13		(4		)	11		7
Gain (loss) reclassified into Cost of sales	12		1		13		—			4		4

Activity related to net investment hedges

Activity related to net investment hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013									2012
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at September 30,	$	557		$	238		$	795		$	527		$	296		$	823
Three months ended September 30:
Gain (loss) on instruments	(18		)	(9		)	(27		)	(6		)	(2		)	(8		)
Gain (loss) on hedged items	18			9			27			8			2			10
Nine months ended September 30:
Gain (loss) on instruments	(8		)	—			(8		)	2			2			4
Gain (loss) on hedged items	9			—			9			(5		)	(2		)	(7		)

Activity related to derivatives not designated as hedging instruments

Activity related to these contracts during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013			2012
	Cross-currency Swap			Cross-currency Swap
Notional Value at September 30,	$	96		$	96
Three months ended September 30:
Gain (loss) on instrument	(6		)	(3		)
Gain (loss) on hedged item	6			3
Nine months ended September 30:
Gain (loss) on instrument	—			(4		)
Gain (loss) on hedged item	—			4

Reconciliation of the Venezuelan investments at fair value

The following table presents a reconciliation of the fair value of the Venezuelan bonds for the nine months endedSeptember 30, 2013 and 2012:

	2013			2012
Beginning balance as of January 1,	$	642		$	236
Unrealized gain (loss) on investment	(124		)	14
Purchases and sales during the period	182			373
Ending balance as of September 30,	$	700		$	623

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2013

Inventory, Net [Abstract]

Inventories By Major Class

Inventories by major class are as follows:

	September 30, 2013		December 31, 2012
Raw materials and supplies	$	340	$	362
Work-in-process	58		81
Finished goods	1,043		922
Total Inventories	$	1,441	$	1,365

XML

Fair Value Measurements and Financial Instruments (Details 3) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 2,656	$ 2,282	$ 2,656	$ 2,282
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	(7)	(3)	(15)	14
Gain (loss) on hedged items	7	3	15	(14)
Fair Value Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	1,568	944	1,568	944
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	(9)	(8)	3	2
Gain (loss) on hedged items	9	8	(3)	(2)
Fair Value Hedging [Member] | Interest Rate Swap Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	1,088	1,338	1,088	1,338
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	2	5	(18)	12
Gain (loss) on hedged items	(2)	(5)	18	(12)
Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	456	373	456	373
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	2	(1)	13	7
Gain (loss) reclassified into Cost of sales	8	3	13	4
Cash Flow Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	441	347	441	347
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	2	(7)	13	(4)
Gain (loss) reclassified into Cost of sales	8	(1)	12	0
Cash Flow Hedging [Member] | Commodity Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	15	26	15	26
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	0	6	0	11
Gain (loss) reclassified into Cost of sales	0	4	1	4
Net Investment Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	795	823	795	823
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	(27)	(8)	(8)	4
Gain (loss) on hedged items	27	10	9	(7)
Net Investment Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	557	527	557	527
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	(18)	(6)	(8)	2
Gain (loss) on hedged items	18	8	9	(5)
Net Investment Hedging [Member] | Foreign Currency Denominated Debt [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	238	296	238	296
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	(9)	(2)	0	2
Gain (loss) on hedged items	9	2	0	(2)
Not Designated as Hedging Instrument [Member] | Cross-Currency Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	96	96	96	96
Activity related to derivatives not designated as hedging instruments [Abstract]
Gain (loss) on instrument	(6)	(3)	0	(4)
Gain (loss) on hedged item	$ 6	$ 3	$ 0	$ 4

XML

Retirement Plans and Other Retiree Benefits (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Contributions by Employer			$ 101	$ 101
United States Pension Benefits [Member]
Components of net periodic benefit cost
Service Cost	6	4	20	18
Interest cost	22	24	68	73
ESOP Offset	0	0	0	0
Expected return on plan assets	(29)	(28)	(88)	(84)
Amortization of transition and prior service costs (credits)	1	2	6	7
Amortization of actuarial loss	17	17	49	46
Net periodic benefit cost	17	19	55	60
International Pension Benefits [Member]
Components of net periodic benefit cost
Service Cost	6	6	16	17
Interest cost	8	9	22	26
ESOP Offset	0	0	0	0
Expected return on plan assets	(7)	(7)	(19)	(19)
Amortization of transition and prior service costs (credits)	1	1	1	1
Amortization of actuarial loss	3	2	10	7
Net periodic benefit cost	11	11	30	32
Other Retiree Benefits [Member]
Components of net periodic benefit cost
Service Cost	3	2	10	8
Interest cost	8	9	28	30
ESOP Offset	0	0	(1)	(1)
Expected return on plan assets	(1)	(1)	(2)	(2)
Amortization of transition and prior service costs (credits)	0	0	0	2
Amortization of actuarial loss	5	5	16	13
Net periodic benefit cost	$ 15	$ 15	$ 51	$ 50

XML

Shareholders' Equity (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			$ 2,390
Net income	699	697	1,809	1,995
Other comprehensive income, net of tax	106	107	(102)	24
Ending balance	2,007		2,007
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	1,767		1,767		1,609
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax	997		997		1,053
Common Stock [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance					1,466
Ending balance	1,466		1,466		1,466
Additional Paid-In Capital [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			818
Stock-based compensation expense			105
Shares issued for stock options			64
Stock issued for restricted stock awards			(72)
Other			(3)
Ending balance	912		912
Unearned Compensation [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			(41)
Other			6
Ending balance	(35)		(35)
Treasury Stock [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			(14,386)
Shares issued for stock options			195
Stock issued for restricted stock awards			72
Treasury stock acquired			(1,115)
Other			(2)
Ending balance	(15,236)		(15,236)
Retained Earnings [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			16,953
Net income			1,677
Dividends			(1,237)
Ending balance	17,393		17,393
Accumulated Other Comprehensive Income (Loss) [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			(2,621)
Other comprehensive income, net of tax			(95)
Ending balance	(2,716)		(2,716)
Noncontrolling Interests [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			201
Net income			132
Other comprehensive income, net of tax			(7)
Dividends			(108)
Other			5
Ending balance	$ 223		$ 223

XML

Earnings Per Share (Details) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Earnings Per Share Reconciliation [Abstract]
Net income attributable to Colgate-Palmolive Company	$ 656	$ 654	$ 1,677	$ 1,874
Basic EPS	656	654	1,677	1,874
Diluted EPS	$ 656	$ 654	$ 1,677	$ 1,874
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic EPS (in shares)	928,100,000	949,800,000	932,500,000	954,800,000
Stock options and restricted stock (in shares)	8,800,000	8,600,000	8,900,000	8,100,000
Diluted EPS (in shares)	936,900,000	958,400,000	941,400,000	962,900,000
Earnings Per Share, Basic and Diluted [Abstract]
Earnings Per Share, Basic	$ 0.71	$ 0.69	$ 1.80	$ 1.96
Earnings Per Share, Diluted	$ 0.70	$ 0.68	$ 1.78	$ 1.95
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,956,750	1,214,526	703,219	1,259,888

XML

Shareholders' Equity

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Shareholders' Equity

Shareholders’ Equity

Changes in the components of Shareholders’ Equity for the nine months endedSeptember 30, 2013 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2012	$	1,466	$	818		$	(41	)	$	(14,386	)	$	16,953		$	(2,621	)	$	201
Net income												1,677						132
Other comprehensive income, net of tax															(95		)	(7		)
Dividends												(1,237		)				(108		)
Stock-based compensation expense			105
Shares issued for stock options			64						195
Shares issued for restricted stock awards			(72		)				72
Treasury stock acquired									(1,115		)
Other			(3		)	6			(2		)							5
Balance, September 30, 2013	$	1,466	$	912		$	(35	)	$	(15,236	)	$	17,393		$	(2,716	)	$	223

Accumulated other comprehensive income (loss) includes cumulative foreign currency translation losses of $1,767 and $1,609 at September 30, 2013 and December 31, 2012, respectively, and unrecognized pension and other retiree benefit costs of $997 and $1,053 at September 30, 2013 and December 31, 2012, respectively.

XML

Acquisitions and Divestitures (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended			9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2013	Sep. 30, 2012
Sale of Land in Mexico [Abstract]
First Installment received from the sale of land in Mexico			$ 24
Second Installment received from the sale of land in Mexico		36
Pretax costs related to sale of land	3	7		14	20
Aftertax costs related to sale of land	$ 2	$ 5		$ 9	$ 15

XML

Fair Value Measurements and Financial Instruments (Details 1) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Derivative and Financial Instruments, Fair Value [Line Items]
Total assets derivatives	$ 35	$ 65
Total liabilities derivatives	12	11
Financial Instruments, Owned, at Fair Value [Abstract]
Total other financial instruments	822	734
Designated derivative instruments
Derivative Assets	35	65
Derivative Liabilities	11	10
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	1	1
Other Current Assets [Member]
Derivative and Financial Instruments, Fair Value [Line Items]
Marketable Securities	146	116
Interest Rate Swap Contracts [Member] | Other Current Assets [Member]
Designated derivative instruments
Derivative Assets	1	3
Interest Rate Swap Contracts [Member] | Other Assets [Member]
Designated derivative instruments
Derivative Assets	22	41
Interest Rate Swap Contracts [Member] | Other Accruals [Member]
Designated derivative instruments
Derivative Liabilities	0	0
Interest Rate Swap Contracts [Member] | Other Liabilities [Member]
Designated derivative instruments
Derivative Liabilities	0	0
Foreign Currency Contracts [Member] | Other Current Assets [Member]
Designated derivative instruments
Derivative Assets	9	7
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Foreign Currency Contracts [Member] | Other Assets [Member]
Designated derivative instruments
Derivative Assets	3	13
Foreign Currency Contracts [Member] | Other Accruals [Member]
Designated derivative instruments
Derivative Liabilities	10	10
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	1	1
Foreign Currency Contracts [Member] | Other Liabilities [Member]
Designated derivative instruments
Derivative Liabilities	1	0
Commodity Contracts [Member] | Other Current Assets [Member]
Designated derivative instruments
Derivative Assets	0	1
Commodity Contracts [Member] | Other Accruals [Member]
Designated derivative instruments
Derivative Liabilities	0	0
Available for Sale Securities | Other Assets [Member]
Financial Instruments, Owned, at Fair Value [Abstract]
Available-for-sale Securities, Fair Value Disclosure	$ 676	$ 618

XML

Other Comprehensive Income

9 Months Ended

Sep. 30, 2013

Other Comprehensive Income (Loss) [Abstract]

Comprehensive Income (Loss) Note

Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedSeptember 30, 2013 and 2012 were as follows:

	2013						2012
	Pre-tax			Net of Tax			Pre-tax			Net of Tax
Cumulative translation adjustments	$	82		$	93		$	79		$	81
Pension and other benefits:
Net actuarial gains (losses) and prior service costs arising during the period	1			1			13			8
Amortization of net actuarial losses, transition and prior service costs (1)	27			17			27			17
Retirement Plan and other retiree benefit adjustments	28			18			40			25
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	4			3			(8		)	(5		)
Reclassification of (gains) losses into net earnings on available-for-sale securities	—			—			—			—
Gains (losses) on available-for-sale securities	4			3			(8		)	(5		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	2			—			(1		)	—
Reclassification of (gains) losses into net earnings on cash flow hedges (2)	(8		)	(5		)	(3		)	(2		)
Gains (losses) on cash flow hedges	(6		)	(5		)	(4		)	(2		)
Total Other comprehensive income (loss)	$	108		$	109		$	107		$	99

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the nine months endedSeptember 30, 2013 and 2012 were as follows:

	2013						2012
	Pre-tax			Net of Tax			Pre-tax			Net of Tax
Cumulative translation adjustments	$	(170	)	$	(158	)	$	(26	)	$	(27	)
Pension and other benefits:
Net actuarial gains (losses) and prior service costs arising during the period	4			3			(19		)	(14		)
Amortization of net actuarial losses, transition and prior service costs (1)	82			53			76			49
Retirement Plan and other retiree benefit adjustments	86			56			57			35
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities	(124		)	(79		)	14			9
Reclassification of (gains) losses into net earnings on available-for-sale securities (2)	133			86			—			—
Gains (losses) on available-for-sale securities	9			7			14			9
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	13			8			7			5
Reclassification of (gains) losses into net earnings on cash flow hedges (3)	(13		)	(8		)	(4		)	(2		)
Gains (losses) on cash flow hedges	—			—			3			3
Total Other comprehensive income (loss)	$	(75	)	$	(95	)	$	48		$	20

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of net periodic benefit cost. See Note 11, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾Represents the one-time loss related to the remeasurement of the fixed interest rate bonds in Venezuela which was recorded in Other (income) expense, net. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

⁽³⁾These (gains) losses are reclassified into Cost of sales. See Note 14, Fair Value Measurements and Financial Instruments for additional details.

XML

Inventories

9 Months Ended

Sep. 30, 2013

Inventory, Net [Abstract]

Inventories

Inventories

Inventories by major class are as follows:

	September 30, 2013		December 31, 2012
Raw materials and supplies	$	340	$	362
Work-in-process	58		81
Finished goods	1,043		922
Total Inventories	$	1,441	$	1,365

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

For a complete set of financial statement notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2012, filed with the Securities and Exchange Commission.

XML

Venezuela (Details) In Millions, except Per Share data, unless otherwise specified	9 Months Ended
	Sep. 30, 2013 USD ($)	Sep. 30, 2012 USD ($)	Sep. 30, 2013 VEF
Notes to Financial Statements [Abstract]
Official currency exchange rate in Venezuela for non-essential goods prior to devaluation beginning Febrauary 13, 2013			4.30
Official currency exchange rate in Venezuela for non-essential goods beginning February 13, 2013			6.30
Pretax Venezuela devaluation charge	$ 172	$ 0
Aftertax Venezuela devaluation charge	111
Impact of aftertax Venezuela devaluation charge per common share diluted	$ 0.12
Percentage of consolidated Net sales represented by CP Venezuela (in hundredths)	4.00%
CP Venezuela's bolivar fuerte-denominated monetary net asset position	530
Fair Value of U.S. dollar-linked, devaluation-protected bonds	$ 257

XML

Restructuring and Related Implementation Charges (Details 2) (Two Thousand Twelve Restructuring Program [Member], USD $) In Millions, unless otherwise specified	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013
Restructuring Reserve [Roll Forward]
Balance	$ 172	$ 89
Charges	30	198
Cash payments	(51)	(103)
Charges against assets	(5)	(38)
Foreign exchange	0	0
Balance	146	146
One-time Termination Benefits [Member]
Restructuring Reserve [Roll Forward]
Balance	141	84
Charges	5	91
Cash payments	(40)	(52)
Charges against assets	0	(17)
Foreign exchange	0	0
Balance	106	106
Incremental Depreciation [Member]
Restructuring Reserve [Roll Forward]
Balance	0	0
Charges	5	20
Cash payments	0	0
Charges against assets	(5)	(20)
Foreign exchange	0	0
Balance	0	0
Asset Impairment [Member]
Restructuring Reserve [Roll Forward]
Balance	0	0
Charges	0	1
Cash payments	0	0
Charges against assets	0	(1)
Foreign exchange	0	0
Balance	0	0
Other Restructuring [Member]
Restructuring Reserve [Roll Forward]
Balance	31	5
Charges	20	86
Cash payments	(11)	(51)
Charges against assets	0	0
Foreign exchange	0	0
Balance	$ 40	$ 40

XML

Segment Information

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Segment Information

Segment Information

The Company has made certain changes in its segment reporting affecting several of the geographic operating segments within its Oral, Personal and Home Care product segment. These changes have no impact on the Company's historical consolidated financial position, results of operations or cash flows.

Effective January 1, 2013, the Company realigned the geographic structure of its North America and Latin America reportable operating segments. In order to better leverage Latin America management's knowledge of emerging market consumers to accelerate growth in the region, management responsibility for the Puerto Rico and CARICOM operations was transferred from North America to Latin America management. Accordingly, commencing with the Company's financial reporting for the quarter ended March 31, 2013, the results of the Puerto Rico and CARICOM operations, which represent less than 1% of the Company's global business, were reported in the Latin America reportable operating segment. Previously, Puerto Rico and CARICOM represented approximately 4% of Net sales of North America and now represent approximately 3% of Net sales of Latin America.

In addition, given the growing importance of the Company's operations in emerging markets, effective with the quarter ended September 30, 2013, the Company is separately reporting financial information for its Asia and Africa/Eurasia operating segments. Previously, the financial information for these operating segments was aggregated into the Greater Asia/Africa reportable operating segment.

The Company has recast its historical geographic segment information to conform to the new reporting structure which results in modification to the geographic components of the Oral, Personal and Home Care segment, with no impact on historical Company results overall.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. Corporate operations include costs related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company in order to measure the underlying performance of the business segments.

Net sales and Operating profit by segment were as follows:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2013			2012			2013			2012
Net sales
Oral, Personal and Home Care
North America	$	774		$	766		$	2,300		$	2,217
Latin America	1,251			1,276			3,747			3,777
Europe/South Pacific	880			865			2,552			2,569
Asia	627			583			1,900			1,717
Africa/Eurasia	321			314			932			918
Total Oral, Personal and Home Care	3,853			3,804			11,431			11,198
Pet Nutrition	545			528			1,628			1,601
Total Net sales	$	4,398		$	4,332		$	13,059		$	12,799
Operating profit
Oral, Personal and Home Care
North America	$	244		$	213		$	686		$	580
Latin America	358			377			1,022			1,100
Europe/South Pacific	216			198			605			560
Asia	174			164			533			474
Africa/Eurasia	65			67			192			197
Total Oral, Personal and Home Care	1,057			1,019			3,038			2,911
Pet Nutrition	138			147			410			440
Corporate	(179		)	(139		)	(784		)	(404		)
Total Operating profit	$	1,016		$	1,027		$	2,664		$	2,947

Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

For the three months ended September 30, 2013, Corporate Operating profit (loss) includes costs of $30 associated with the 2012 Restructuring Program and costs of $3 related to the sale of land in Mexico. For the nine months endedSeptember 30, 2013, Corporate Operating profit (loss) includes costs of $198 associated with 2012 Restructuring Program, a one-time $172 charge for the impact of the devaluation in Venezuela, a charge of $18 for a competition law matter in France related to the home care and personal care sectors and costs of $14 related to the sale of land in Mexico. For further information regarding the 2012 Restructuring Program, refer to Note 5, Restructuring and Related Implementation Charges. For further information regarding the Venezuela devaluation, refer to Note 15, Venezuela. For further information regarding the competition law matter in France, refer to Note 12, Contingencies. For further information regarding the sale of land in Mexico, refer to Note 4, Acquisitions and Divestitures. For the three months ended September 30, 2012, Corporate Operating profit (loss) included costs of $7 related to the sale of land in Mexico and costs of $3 associated with various business realignment and other cost-saving initiatives. For the nine months endedSeptember 30, 2012, Corporate Operating profit (loss) included costs of $20 related to the sale of land in Mexico and costs of $21 associated with various business realignment and other cost-saving initiatives.

XML

Common Stock Split

9 Months Ended

Sep. 30, 2013

Common Stock Split [Abstract]

Common Stock Split Note Disclosure

Common Stock Split

On March 7, 2013, the Company's Board of Directors approved a two-for-one stock split of the Company's common stock to be effected through a 100% stock dividend. The record date for the two-for-one split was the close of business on April 23, 2013, and the share distribution occurred on May 15, 2013. As a result of the split, shareholders received one additional share of Colgate common stock, par value $1.00, for each share they held as of the record date.

All per share amounts and number of shares outstanding in these Condensed Consolidated Financial Statements and Notes to the Condensed Consolidated Financial Statements are presented on a post-split basis.

In addition, the impact on the Balance Sheet as a result of the stock split was an increase of $733 to Common Stock and an offsetting reduction in Additional paid-in capital, which has been retroactively restated.

XML

Restructuring and Related Implementation Charges (Tables)

9 Months Ended

Sep. 30, 2013

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

For the three and nine months ended September 30, 2013, restructuring and implementation-related charges are reflected in the income statement as follows:

	Three Months Ended		Nine Months Ended
	September 30, 2013		September 30, 2013
Cost of sales	$	8	$	26
Selling, general and administrative expenses	9		31
Other (income) expense, net	13		141
Total 2012 Restructuring Program charges, pretax	$	30	$	198
Total 2012 Restructuring Program charges, aftertax	$	22	$	153

Schedule of Restructuring and Related Costs Incurred to Date

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $287 ($223 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of September 30, 2013
Employee-Related Costs	$	169
Incremental Depreciation	20
Asset Impairments	1
Other	97
Total	$	287

Schedule of Restructuring Reserve by Type of Cost

The following tables summarize the activity for the restructuring and implementation-related charges discussed above and the related accrual:

	Three Months Ended September 30, 2013
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at June 30, 2013	$	141		$	—		$	—	$	31		$	172
Charges	5			5			—		20			30
Cash payments	(40		)	—			—		(11		)	(51		)
Charges against assets	—			(5		)	—		—			(5		)
Foreign exchange	—			—			—		—			—
Balance at September 30, 2013	$	106		$	—		$	—	$	40		$	146

	Nine Months Ended September 30, 2013
	Employee-Related Costs			Incremental Depreciation			Asset Impairments			Other			Total
Balance at December 31, 2012	$	84		$	—		$	—		$	5		$	89
Charges	91			20			1			86			198
Cash payments	(52		)	—			—			(51		)	(103		)
Charges against assets	(17		)	(20		)	(1		)	—			(38		)
Foreign exchange	—			—			—			—			—
Balance at September 30, 2013	$	106		$	—		$	—		$	40		$	146

XML

Fair Value Measurements and Financial Instruments

9 Months Ended

Sep. 30, 2013

Fair Value Measurements and Financial Instruments [Abstract]

Fair Value Measurements and Financial Instruments

Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to credit losses in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, supplier agreements, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). Foreign currency contracts consist of forward, option and swap contracts utilized to hedge a portion of the Company’s foreign currency purchases, assets and liabilities arising in the normal course of business as well as the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in the Company’s operations. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed twelve months.

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at September 30, 2013 and December 31, 2012:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		9/30/13		12/31/12			9/30/13		12/31/12
Interest rate swap contracts	Other current assets	$	1	$	3	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	22		41		Other liabilities	—		—
Foreign currency contracts	Other current assets	9		7		Other accruals	10		10
Foreign currency contracts	Other assets	3		13		Other liabilities	1		—
Commodity contracts	Other current assets	—		1		Other accruals	—		—
Total designated		$	35	$	65		$	11	$	10
Derivatives not designated
Foreign currency contracts	Other current assets	$	—	$	—	Other accruals	$	1	$	1
Total not designated		$	—	$	—		$	1	$	1
Total derivative instruments		$	35	$	65		$	12	$	11
Other financial instruments
Marketable securities	Other current assets	$	146	$	116
Available-for-sale securities	Other assets	676		618
Total other financial instruments		$	822	$	734

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of September 30, 2013 and December 31, 2012. The estimated fair value of the Company’s long-term debt, including the current portion, as of September 30, 2013 and December 31, 2012, was $5,465 and $5,484, respectively, and the related carrying value was $5,265 and $5,176, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

Fair value hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting loss or gain on the hedged item are recognized in current earnings. The impact of foreign currency contracts is recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest expense, net.

Activity related to fair value hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013									2012
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at September 30,	$	1,568		$	1,088		$	2,656		$	944		$	1,338		$	2,282
Three months ended September 30:
Gain (loss) on derivative	(9		)	2			(7		)	(8		)	5			(3		)
Gain (loss) on hedged items	9			(2		)	7			8			(5		)	3
Nine months ended September 30:
Gain (loss) on derivative	3			(18		)	(15		)	2			12			14
Gain (loss) on hedged items	(3		)	18			15			(2		)	(12		)	(14		)

Cash flow hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (OCI) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013						2012
	Foreign Currency Contracts		Commodity Contracts		Total		Foreign Currency Contracts			Commodity Contracts		Total
Notional Value at September 30,	$	441	$	15	$	456	$	347		$	26	$	373
Three months ended September 30:
Gain (loss) recognized in OCI	2		—		2		(7		)	6		(1		)
Gain (loss) reclassified into Cost of sales	8		—		8		(1		)	4		3
Nine months ended September 30:
Gain (loss) recognized in OCI	13		—		13		(4		)	11		7
Gain (loss) reclassified into Cost of sales	12		1		13		—			4		4

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.

Net investment hedges

The Company has designated certain foreign currency forward contracts, option contracts and foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Currency translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

Activity related to net investment hedges recorded during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013									2012
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at September 30,	$	557		$	238		$	795		$	527		$	296		$	823
Three months ended September 30:
Gain (loss) on instruments	(18		)	(9		)	(27		)	(6		)	(2		)	(8		)
Gain (loss) on hedged items	18			9			27			8			2			10
Nine months ended September 30:
Gain (loss) on instruments	(8		)	—			(8		)	2			2			4
Gain (loss) on hedged items	9			—			9			(5		)	(2		)	(7		)

Derivatives Not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. 

Activity related to these contracts during the three-month and nine-month periods ended September 30, 2013 and 2012 was as follows:

	2013			2012
	Cross-currency Swap			Cross-currency Swap
Notional Value at September 30,	$	96		$	96
Three months ended September 30:
Gain (loss) on instrument	(6		)	(3		)
Gain (loss) on hedged item	6			3
Nine months ended September 30:
Gain (loss) on instrument	—			(4		)
Gain (loss) on hedged item	—			4

Other Financial Instruments

Other financial instruments are classified as Other current assets or Other assets.

Other financial instruments classified as Other current assets include marketable securities, which consist of bank deposits of $122 with original maturities greater than 90 days (Level 1 valuation) and the current portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $24. The long-term portion of these bonds in the amount of $676 is included in Other assets.

Through its subsidiary in Venezuela, the Company is invested in U.S. dollar-linked, devaluation-protected bonds and fixed interest rate bonds, both of which are issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of September 30, 2013, the U.S. dollar-linked, devaluation protected bonds and the fixed interest rate bonds had fair market values of $257 and $443, respectively. These investments are considered available-for-sale securities and, as noted above, $24 is included in Other current assets and $676 is included in Other assets.

The following table presents a reconciliation of the fair value of the Venezuelan bonds for the nine months endedSeptember 30, 2013 and 2012:

	2013			2012
Beginning balance as of January 1,	$	642		$	236
Unrealized gain (loss) on investment	(124		)	14
Purchases and sales during the period	182			373
Ending balance as of September 30,	$	700		$	623

The Unrealized loss on investment consisted primarily of a one-time loss of $133 in the first quarter of 2013 related to the remeasurement of the fixed interest rate bonds at February 9, 2013, the date of the devaluation. For further information regarding Venezuela and the devaluation, refer to Note 15, Venezuela below.

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2013
Entity Information [Line Items]
Entity Registrant Name	COLGATE PALMOLIVE CO
Entity Central Index Key	0000021665
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	925,208,785
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2013

XML

Venezuela

9 Months Ended

Sep. 30, 2013

Notes to Financial Statements [Abstract]

Venezuela

Venezuela

Venezuela has been designated hyper-inflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (“CP Venezuela”) is the U.S. dollar and Venezuelan currency fluctuations are reported in income.

The Venezuelan government devalued its currency effective February 9, 2013. As a result of the devaluation the official exchange rate changed from 4.30 to 6.30 Venezuela bolivares fuerte per dollar. The Company incurred a one-time, pretax loss of $172 ($111 aftertax loss) in the first quarter of 2013 related to the remeasurement of the net monetary assets included in the local balance sheet at the date of the devaluation. The impact of this one-time aftertax loss of $111 on diluted earnings per common share was $0.12 for the nine months endedSeptember 30, 2013. The Company remeasured the financial statements of CP Venezuela at the rate at which it currently expects to remit future dividends, which is 6.30. As the local currency operations in Venezuela translated into fewer U.S. dollars, this had and will continue to have an ongoing adverse effect on the Company's reported results.

For the nine months endedSeptember 30, 2013, CP Venezuela represented approximately 4% of the Company’s consolidated Net sales. At September 30, 2013, CP Venezuela’s bolivar fuerte-denominated net monetary asset position, which would be subject to remeasurement in the event of a further devaluation, was approximately $530. This amount does not include $257 of devaluation-protected bonds issued by the Venezuelan government, as these bonds provide protection against devaluations by adjusting the amount of bolivares fuerte received at maturity for any devaluation subsequent to issuance.